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Introduction
The impact of chronic neuropathic pain
Chronic pain can be severely disabling and represents a greatly underestimated public 
health problem.  “Pain can kill. It can kill the spirit, vitality and the will to live,” said 
Joel Saper, MD and president of the American Headache Society, in response to law 
the US Congress passed into provision in late 2000, declaring the following decade 
( January 1st 2001 – 2011) as the Decade of Pain Control and Research.1 A critical 
goal of the Decade of Pain initiative was to maximize the public and professional 
understanding of pain and pain management.  
Approximately 20% of adult Europeans suffer from chronic pain of moderate to 
severe intensity, seriously affecting the quality of their social and working lives.2 Neu-
ropathic pain is thought to be a particularly distressing chronic pain condition that 
is often under-diagnosed and under-treated.3 Neuropathic pain has been defined as 
pain arising as a direct consequence of a lesion or disease affecting the somatosensory 
system,4 and is often therapy resistant for reasons largely unknown.5 Pain intensity 
and duration are reported to be higher in comparison to chronic pain without neuro-
pathic characteristics.6 Recently published studies involving epidemiological surveys 
in Europe suggested neuropathic pain to have a prevalence of 7–8% in the general 
population.6,7 
Approximately 3-5% of all patients involved in peripheral nerve injury develop 
a symptomatic neuroma.8,9 In the Netherlands, there are approximately 3.5/100,000 
or 580 new cases of neuropathic pain caused by traumatic or iatrogenic nerve injury 
every year.10 
Symptomatic neuromas cause intense spontaneous burning, shooting or electric 
pain as well as lowered thresholds for pain (hyperalgesia) and pain at touch (allodynia) 
or mild cold (cold intolerance).11 Nerve injuries most frequently involve the upper 
extremity.12 Blue collar workers in factories operating various kinds of machinery are 
especially prone to upper extremity trauma. Since hand function is one of the most 
important bodily functions,13 a painful neuroma in the upper extremity results in great 
disability, especially when the dominant side is affected. In the Guide to the Evalu-
ation of Permanent Impairment’ of the American Medical Association (AMA-5), 
loss of function of one hand was estimated as a physical disability of 30-60%.14 The 
social disability compensation can add up to €19,500 per patient annually, based on 
the Dutch standard income.
Neuroma pain brings tremendous direct and indirect costs to patients and their 
families in terms of pain and suffering, quality of life and health care expenditures, as 
well as costs to society in health-insurance claims, lost productivity and occupational 
disability.2,3,5,15,16
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Clinical case
The following case illustrates the impact of painful neuromas in clinical practice. It 
describes a true neuroma pain patient who presented at the outpatient clinic of the 
Department of Plastic and Reconstructive Surgery of the Erasmus Medical Center in 
August 2008.
Mr. Dolor is a 32 year old right-handed plastic processor. He is married, has 2 young 
children and likes to play computer games. He has no relevant medical history, and 
is a smoker. In March 2007 he sustained an occupational injury when his right hand 
got caught in a milling machine (Dutch: freesmachine). There was an injury to the 
thumb base, treated with a full thickness skin graft in a secondary care hospital.
In August 2008 he was referred to the Erasmus Medical Center for complaints of 
neuropathic pain and dysesthesias. The clinical exam showed areas of numbness, 
hyperalgesia, allodynia and cold intolerance in the thenar region and there was a 
positive Tinel’s sign over the superficial branch of the radial nerve (SBRN). There 
were no signs of complex regional pain syndrome (CRPS) and motor function was 
intact.
Mr. Dolor was diagnosed with a painful neuroma of the SBRN and treated with 
EMLA cream and iontophoresis for several months, without substantial effect. In 
January 2009, he sustained surgical relocation of the SBRN into the thenar muscu-
lature. When visiting the outpatient clinic in July 2009, he still experienced extreme 
neuropathic pain, especially in cold weather. The adjuvant pain medication he was 
prescribed made him drowsy. He remained restricted in his activities of daily living 
(ADL), including lifting with his right hand, writing, work and leisure activities, and 
performing his family role. He was now unemployed, received social disability com-
pensation (WIA), and was involved in a litigation process against his employer. He 
indicated he would like to receive help from a psychologist, since he had lost all 
hope to ever become pain-free.  
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Peripheral nerve injury and regeneration
The incidence of peripheral nerve injury is estimated at 1.6 - 2.8% in patients with 
upper- or lower extremity trauma.12,17 The majority of patients is between 18 and 
35 years of age and peripheral nerve injuries occur more frequently in males than 
females. The leading causes are motor vehicle accidents, occupational injuries or 
aggression.12,18  Type of injury can be categorized as being sharp (i.e. glass, knives, 
surgical procedures) crush (i.e. falls, heavy machinery) or avulsion (i.e. deglovement, 
milling accidents). Although sharp injuries are more common, crush injuries have the 
highest chance of peripheral nerve injury.17 
Peripheral nerve injury leads to a series of cellular responses. Axons distal 
to the injury site degenerate and local Schwann cells and macrophages clear the 
distal endoneurial tubes of apoptotic debris. This is called Wallerian degeneration. 
The severed axon end begins to sprout within 24 hours after injury, and individual 
axons may produce more than one sprout.19 Neurotrophic factors (i.e. BDNF, NGF), 
released by macrophages and Schwann cells, direct the regenerating axons and induce 
axon maturation and elongation into the endoneural sheaths.19,20 The rate of axonal 
outgrowth is 1-5 mm/day, and, therefore, may take several months for regenerating 
axons to reinnervate their distal targets.9 Large gaps, i.e. gaps over 15-30 mm, usually 
cannot be bridged by axons.  Proliferating fibroblasts and newly formed scar tissue can 
form a physical blockade. When a blockade between the proximal and distal stump 
is present, or the distal stump is lost e.g. in case of amputation, nerve proliferation 
continues with a high chance of neuroma formation.21  
figure 1. Wallerian degeneration
A: cutaneous nerve
B: nerve damage and Wallerian  
degeneration of the distal nerve end. 
Macrophages remove debris
C: axon sprouting and Schwann cell 
proliferation (desired situation)
D: neuroma formation (undesired 
situation)
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History, definition and pathogenesis of painful neuromas
Painful neuromas have first been described by Ambroise Paré, a 16th century military 
surgeon, who published a detailed description of what we now call causalgia following 
a nerve injury inflicted on King Charles IX of France. He also observed that patients 
who underwent a surgical amputation continued to experience pain long after the 
procedure. The first scientific description of neuroma formation appeared in 1811 by 
Odier, who described the bulbous nerve swellings which develop at the distal end of 
the proximal peripheral nerve stumps after partial or complete division. In 1863 an 
initial histologic analysis and classification system for neuromas was established by 
Virchow.22,23
A neuroma is formed by simultaneous regeneration of neural fibers and excessive 
fibrous tissue proliferation, which results in contraction of nerve fibers within the scar 
tissue.21 It consists of tangled axons, Schwann cells, endoneurial cells, and perineurial 
cells in a dense collagenous matrix with surrounding fibroblasts.24
Approximately 3-5% of all patients involved in peripheral nerve injury develop 
a symptomatic neuroma,8 and asymptomatic neuromas often remain unnoticed. 
Although it is a topic of great interest for neuroma research, there is no consensus on 
why some neuromas become painful and others do not. 
In symptomatic neuromas, there is sensitization of nociceptive nerve fibers 
due to an up-regulation of sodium channels, adrenergic and nicotinic cholinergic 
receptors.25-29 In addition, ephaptic conduction or “cross-talk” between adjacent 
nerve fibers can take place leading to abnormal sensitivity and spontaneous activity 
of axons in the neuroma.30 As ectopic peripheral nerve input continues, changes in 
neural structures involved in pain perception, i.e. the dorsal root ganglion, the dorsal 
horn of the spinal cord, thalamus and sensory cortex, start to take place: There is 
increased excitability of neurons in adjacent spinal segments and cortical areas, also 
called ‘central sensitization’.30,31 
Furthermore, there is increasing evidence that mechanical and thermal hyperal-
gesia and allodynia are independent of spontaneous pain originating in the peripheral 
neuroma.32-35 This suggests recruitment of axons from adjacent nerves,32,36 changes in 
the processing of stimuli from intact neighboring nerve fibers,34 or direct injury to 
surrounding nerve branches.37,38
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Diagnosis, treatment and prognosis
The diagnosis of neuroma-specific neuropathic pain is primarily based on clinical 
judgment. Patients usually present with a history of nerve injury to the upper extremity, 
followed by symptoms of a painful neuroma. These include negative (hypoesthesia) 
and positive sensory signs (pinprick hyperalgesia, dynamic mechanical allodynia, 
pressure hyperalgesia, cold intolerance and spontaneous pain) in the distribution of 
a peripheral sensory nerve. When tapping the injured nerve, patients typically show 
a shooting electrical pain in the distribution of the nerve (positive Tinel’s test). This 
test can be used to locate the ends of transected and regenerating axons.39 Using 
quantitative sensory testing (Von Frey monofilaments) and 2-point discrimination 
(2PD), the exact areas of hypoesthesia corresponding to the injured nerve branches 
can be mapped out.30
In most cases, a temporary diagnostic nerve block with 1% lidocaine is performed 
at the outpatient clinic, to confirm involvement of the suspected peripheral nerve 
in the painful sensation.38  The outcome of this test is often decisive for the treat-
ment plan: insufficient pain relief following a diagnostic block is often considered a 
contraindication to surgery.40 Unfortunately, the exact predictive value of this test is 
currently unknown and statistical evidence seems to be lacking.41 
figure 2. Innervation of the distal upper extremity
LABCN: lateral anterbrachial cutaneous nerve; 
MBCN: medial antebrachial cuteneous nerve
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If there is remaining doubt concerning the diagnosis following the clinical 
examination, the patient can be sent for nerve conduction studies to evaluate the loca-
tion and extent of the possible nerve injury.30 Although studies have been performed 
in visualizing neuromas of major peripheral nerves using ultrasonography,42,43  it is not 
yet commonly used in the diagnosis, localization or follow up of neuroma pain. This 
is because of previously inadequate scanning frequencies for detailed visualization e.g. 
of small cutaneous nerve branches. When the nerve involved in the painful neuroma is 
identified, treatment starts with at least 6 months of non-operative therapy including 
scar massage, local application of lidocaine cream, iontophoresis (transdermal appli-
cation of local anesthetic using electrical current) and desensitization with vibrations 
or light sandpaper. More invasive techniques, such as injections of the nerve stump 
with various chemical agents, spinal cord stimulation, transcutaneous electrical nerve 
stimulation (TENS) and repeated nerve blocks have also been applied, with limited 
success.31 Neuroma pain patients are often prescribed adjuvant pain medication like 
antidepressants and anticonvulsants.44
As opposed to the life-long use of analgesic medication or medical devices, surgical 
neuroma treatment, if successful, can provide a permanent effect on pain relief. When 
the target organ or distal nerve end is present, reinnervation should be attempted by 
reconstruction of the injured nerve. There should be minimal tension on the repaired 
nerve, and in case of a nerve gap a nerve graft or neurotube can be used to guide 
axonal regeneration. In case of a painful neuroma in continuity preserving functional 
sensitivity should be attempted. In this case a muscle flap can be used to reduce 
symptoms from mechanical stimulation of the neuroma.29 273
When the distal nerve end is not available for reconstruction, as in amputation 
injuries, the proximal nerve end is usually relocated into an environment away from 
the original injury site, for example into bone, muscle or vein, where it is protected 
from mechanical or thermal stimulation and excessive concentrations of neural growth 
factors.21,45 Mackinnon et al.24 showed that neuromas that are formed after relocation 
of the nerve end into innervated and well vascularized muscle show significantly less 
scar tissue with a decreased density of less well myelinated nerve fibers. Other tech-
niques proposed in literature include simple ligation, sealing or capping of the nerve 
and end-to-side anastomoses or nerve loops.45,46 
Since treatment failure is common, accurate patient selection for surgical 
neuroma treatment is essential. Patient-specific prognostic factors, predicting insuf-
ficient pain relief after surgical neuroma treatment, can help clinicians in the process 
of patient selection and informing, treatment and care. They may also provide new 
surgical treatment strategies for patients that would otherwise have an unfavorable 
chance for adequate pain relief. Furthermore, there are many important determinants 
of patient satisfaction in chronic pain treatment, which are currently under-studied 
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and undertreated. These include disability, quality of life, psycho-social problems and 
cold intolerance.
Unfortunately, most studies that have been performed evaluating surgical man-
agement of the painful neuroma have had a retrospective design 47-49, or comprised case 
series with minimal patient numbers.50-58 Other studies used ill defined or non vali-
dated outcome measures for pain 40,49,59-62, or did not assess other important aspects in 
the treatment of chronic pain, like upper extremity disability or quality of life.52,53,62-65. 
This is probably due to the reasonably low incidence of painful neuromas making 
large study populations are hard to obtain in a prospective setting. However, well-
designed, clinical epidemiological studies may provide a step forward in the surgical 
management of painful neuromas.
figure 3. Neuroma of the superficial branch of the radial nerve
Photo: AVD Erasmus MC. Printed with patient’s permission
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Objective and research questions 
The purpose of this thesis was to explore why a large number of patients with neuroma 
pain still have insufficient pain relief following surgical neuroma treatment, and to 
explore the optimal strategies for surgical treatment and chronic pain prevention of 
individual patients. 
To achieve the objective of this thesis, we need the answer to the following research 
questions:
Which are important prognostic factors for insufficient pain relief?- 
Can we use ultrasonography for diagnosis and localization of neuromas in the - 
upper extremity?
Is the diagnostic nerve block a predictive diagnostic tool?- 
Can hyperalgesia be sustained by pain conduction via adjacent nerves; and how - 
can we treat this hyperalgesia?
Which are the most important outcome measures for peripheral neuropathic - 
pain research? 
What is the most effective treatment strategy for neuroma pain patients? - 
These questions will be addressed in chapters 2-7 of this thesis.
19
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Outline of the thesis
Chapter 2 is a review of the literature concerning prognostic factors for insufficient 
pain relief following surgical neuroma treatment. It also focuses on the process of 
central sensitization that occurs in neuroma pain patients.
In Chapter 3 we explored the potential of high-resolution ultrasonography for the 
visualization of the small cutaneous nerve branches in the hand and wrist that are 
often involved in neuroma formation.
In Chapter 4 we studied the prevalence of cold intolerance or thermal hyperalgesia 
in neuroma pain patients, and the improvement of these symptoms following surgical 
denervation. 
Chapter 5 is a retrospective study on the surgical treatment of SBRN neuralgia. We 
looked at etiology and compared different treatment methods, including neurectomies 
of adjacent nerves. 
In Chapter 6 we evaluated the importance of several major outcome measures for 
patient satisfaction following surgical neuroma treatment. We determined cut-off 
scores for reliable and clinically significant change in these outcomes. 
Chapter 7 presents the results from our prospective prognostic cohort study. In this 
study we evaluated the effect of surgical neuroma treatment on important outcome 
measures evaluated in chapter 6. Possible prognostic factors were investigated and the 
predictive value of the commonly used diagnostic nerve block was determined. 
In Chapter 8 the results from the previous chapters and their implications are dis-
cussed. The research questions will be answered and the main objective evaluated. The 
conclusions and recommendations of this thesis are presented, as well as possibilities 
for future research.
20
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Insufficient pain relief after surgical neuroma treatment 
Chapter 2:
Insufficient pain relief after surgical 
neuroma treatment 
Insuff icient pain relief after surgical neuroma treatment: prognostic factors and central 
sensitization. Stokvis A, Coert JH, Van Neck JW. J Plast Reconstr Aesthet Surg. In press, 
published online. 2009; doi:10.1016/j.bjps.2009.05.036
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Abstract
Background: 
Treatment of patients with neuromatous pain is difficult. Numerous treatment 
methods have been described, but none has been completely effective in providing 
sufficient pain relief. Patient specific prognostic factors, predicting pain after surgical 
neuroma treatment, can help clinicians in the process of patient treatment and care.
Methods: 
A computerized bibliographical database (PubMed Medline) was searched for articles 
concerning prognostic factors predicting the outcome of surgical neuroma treatment, 
and all reference lists were checked.
Results: 
Evidence for predicting the outcome was found for neuromas of the radial sensory 
branch and digital nerves, discrete nerve syndrome, workers compensation, employ-
ment status, litigation involvement, duration of pain, and number of previous opera-
tions. Psychosocial problems are often found in neuroma patients. In chronic neuro-
pathic pain patients, changes in the central nervous system at the spinal cord level and 
in the somatosensory cortex can be found.
Conclusions: 
Neuromas of the radial sensory branch and digital nerves, discrete nerve syndrome, 
workers compensation, employment status, litigation involvement, duration of pain 
and number of previous operations appear to predict the amount of pain after neuroma 
surgery. However, in a minority of patients the bad outcome cannot be explained by 
these factors; in these patients central sensitization and psychosocial factors may play 
a role in maintaining pain. Research focusing on prognostic factors and the central 
changes induced by painful peripheral injury can lead to new and improved clinical 
treatment algorithms for the relief and prevention of chronic neuropathic pain.
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Introduction
When a peripheral nerve is damaged, it will try to regenerate itself toward the distal 
nerve end or target organ.1 If a distal target is not found, axon sprouts grow into the 
surrounding scar tissue forming a neuroma.2-4 Some of these neuromas cause intense 
pain, cold intolerance, altered sensation and hypersensitivity in the distribution of the 
injured nerve.5 This causes loss of function and has a great impact on the daily life 
of patients. Neuropathic pain can be psychologically and physically disabling.6 In a 
retrospective study of patients with digital amputations, Fisher and Boswick7 found 
the painful neuroma to have an incidence of less than 4%. However, according to 
Koch et al.8 as many as 30% of all neuromas are painful. 
Neuropathic pain is very difficult to treat and often evolves into a chronic 
pain disorder.9 The key to neuroma management is prevention by directly repairing 
damaged nerves and restoring functionality. Once the neuroma has formed, the best 
results are usually obtained from surgical intervention.5,10 Vernadakis et al.5, Whipple 
and Unsell11 have formulated surgical treatment algorithms that describe the basic 
principles of surgical management of neuromas throughout the body; usually by relo-
cation of the nerve end into muscle or bone.
Despite numerous treatment methods and careful patient selection, it appears 
that 0 to 67% of neuroma patients do not benefit from surgical intervention.5,12-21 
Patient-specific prognostic factors, predicting insufficient pain relief after surgi-
cal neuroma treatment, can help clinicians in the process of patient selection, treat-
ment and care. In the literature concerning prognostic factors of surgical neuroma 
treatment, the focus has mainly been on demographic and physical determinants. 
In some patients there is no visible cause related to the peripheral nerve to 
explain persistent pain after surgery.12,13,20,22. Central sensitization and psychosocial 
factors may play a role in maintaining pain in these patients.7,13,18,21
The focus of this review is the literature concerning the prediction of outcome in 
surgically-treated neuroma patients. Besides the often-described prognostic factors, 
also the relatively new area of psychosocial factors and central centralization is 
addressed, as are possibilities for future research and treatment. 
Methods
A computerised bibliographical database (PubMed Medline) was searched for cita-
tions concerning neuromas of peripheral nerves. Criteria included research in humans, 
publications in the English language only and case reports or series were excluded. 
The titles of citation printouts were reviewed, abstracts identified as being potentially 
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related to our topic were retrieved, and reference lists were checked for their relevance 
to our study. Prospective or retrospective cohort studies on the surgical treatment of 
painful neuromas of the extremities of at least five patients were included. 
Results and discussion
The initial Medline search yielded 114 results, of which 51 titles matched our search 
criteria. After scrutinizing the references 61 articles were retrieved. We found 14 
articles that mention possible prognostic factors or try to give an explanation for the 
observed surgical results7,12,13,15,16,18,19,21,23-28. Major prognostic factors were found to be 
similar among the studies (Table 1).
The factors that seem to predict the amount of postoperative pain in surgically-
treated neuroma patients are: neuromas of the radial sensory branch (RSB) and digital 
nerves, discrete nerve syndrome, workers compensation, employment status, litigation 
involvement, duration of pain, and number of previous operations. These prognostic 
factors are discussed separately below.
Radial sensory branch neuromas
The apparent susceptibility of the RSB to form painful neuromas has been well 
documented.15,16,19,23 An anatomical mechanism causing the predisposition of the RSB 
to develop painful neuromas has been proposed.23 The RSB is located in close prox-
imity to the wrist joint, is subject to substantial traction and lies relatively superficial 
in the skin, exposing it to repetitive mechanical/stretch trauma. Proximal tethering of 
this nerve as it exits from the deep fascia increases nerve tension. This could increase 
scar formation and, therefore, promote neuroma formation. Dorsoradial wrist neuro-
mas remain the most difficult for which to achieve satisfactory pain relief.27
Treatment failure can be caused by placing the RSB into a muscle with significant 
excursion. For instance, placing the nerve end in the thenar muscle group can lead to 
significant pain with movement of the thumb, also limiting hand function. Dellon and 
Mackinnon13 reported that all four patients who underwent this procedure had to be 
reoperated with subsequent placement of the nerve in the brachioradialis muscle. The 
brachioradialis muscle has little excursion and, therefore, contraction does not induce 
substantial traction on the nerve. This makes the brachioradialis muscle very suitable 
for RSB implantation.18,29
Another cause for treatment failure in patients with a RSB neuroma is misdi-
agnosis of an overlapping sensory pattern of the lateral antebrachial cutaneous nerve 
(LABCN) with the RSB.13,27 Mackinnon and Dellon27 found concomitant injury to 
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the RSB and the LABCN in 38 of all 52 patients with persistent dorsoradial wrist 
pain related to a neuroma of the RSB. Misdiagnosis may be avoided by the use of local 
diagnostic nerve blocks to confirm the exact source of the pain.27 
Digital nerves
Patients with neuromas of digital nerves seem prone to persistent pain after surgery. 
Novak et al.18 found that neuromas of the digital nerves were strongly related to 
poor subjective outcome; improvement was seen in only 12 of 22 digital nerve neu-
romas. Dellon and Mackinnon13 treated seven patients with digital neuromas with 
poor results: 86% of these patients also remained little improved or unchanged. None 
of the patients achieved excellent relief of pain. The difference in outcome between 
neuromas located in the digital nerve and other nerve locations was significant at p 
< 0.0005. 
The high failure rate of these operations was probably due to placement of the 
nerve endings in the intrinsic muscles of the hand. These intrinsic muscles are small 
and display relatively large excursions, causing pain at movement or contact.13,15 Hazari 
and Elliot25 investigated multiple methods for relocation of digital nerve neuromas. 
They observed the poorest results in therapeutical ray amputations and concluded 
that treatment of digital neuromas should be based on the relocation of the nerve ends 
into a more proximal and deeper site, distant from the scar area and locations subject 
to repeated minor trauma.15,28 Relocation into the phalangeal or metacarpal bones 
seems to be the most effective treatment in patients with digital neuromas.6,14,25,28
Discrete nerve syndrome
Burchiel et al.12 described the concept of a discrete nerve syndrome. This is a collective 
term for physical findings associated with complex regional pain syndrome, mechani-
cal or thermal hyperalgesia and the presence of Tinel’s sign. It is a condition in which 
a single nerve can account for both the neurological findings and the distribution 
of neuropathic pain. As expected, poorly localized, ill-defined signs and symptoms 
predict bad outcome. Discrete nerve syndrome, as a combined variable, demonstrated 
a moderate correlation with pain improvement (p = 0.08).
Workers compensation 
Workers compensation is often mentioned as predictive of continued pain and loss of 
function.7,13,18,30-33 Dellon and Mackinnon13 found a significant difference in the per-
centage of excellent pain relief between patients with and without workers compensa-
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tion (p < 0.01). Of all patients receiving workers compensation, 35% had an excellent 
outcome, while this was 75% for the patients without workers compensation. 
Using a telephone survey to evaluate long-term subjective outcome, Novak et 
al.18 also found workers compensation to be significantly related to poor subjective 
outcome (p < 0.03). Patients whose pain is job related may be difficult to evaluate 
postoperatively in terms of impairment and job restrictions,24 as patients involved in 
workers compensation may have an interest in reporting poor outcome.7 
The issue of compensation can also have a great impact on patient’s lives. A 
condition called compensation neurosis might explain the bad results in patients 
receiving workers compensation. In this condition, psychological symptoms occur 
after an injury in which a compensation claim is possible or pending and symptoms 
are maintained by the patient’s wish for monetary compensation.30-33
Burchiel et al.12 found that patients who were receiving workers compensation 
did no worse than the group as a whole. Mackinnon and Dellon27 argued that workers 
compensation cannot be seen separately from their employment status. 
Employment status
Dworkin et al.32 stated that the effect of workers compensation on outcome is not 
caused by compensation or litigation, but by actual employment status. In their study 
the poor prognostic effect of workers compensation disappeared when controlled for 
employment status; they argued it would be valuable to focus on activity and employ-
ment instead of the deteriorating effects of compensation neurosis in the treatment 
and rehabilitation of chronic pain patients. When Mackinnon and Dellon27 looked 
at the employment status of patients receiving workers compensation, it was evident 
that patients who were employed and working achieved better results than those who 
were unemployed (p < 0.01), supporting Dworkin’s theory. Furthermore, Novak et 
al.18  found a significant difference in length of time off work preoperatively between 
patients who returned to work and those who did not (p < 0.05).
In a more recent paper, Suter30 suggests that, in chronic pain patients, employ-
ment may lead to lower physical and emotional distress, particularly for those patients 
receiving workers compensation or involved in litigation. 
Litigation involvement
There has been inconsistent evidence regarding the relationship between litiga-
tion status and chronic pain. Dworkin et al.32 found that litigation involvement did 
not predict long-term outcome, only employment did.
However, Suter30 demonstrated that involvement in litigation was associated with 
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increased pain, depression and disability in patients with chronic pain. This effect was 
independent of their employment status. Patients seem to benefit less from treatment 
when continued disability may be important for their pending litigation.7 Burchiel et 
al.12 showed near statistical significance for litigation as a predictive factor. 
Duration of pain
Mackinnon and Dellon27 compared the duration of pain prior to surgery in a group 
of patients with poor pain relief to the patients with good or excellent pain relief 
following surgery. The group with poor pain relief had a median duration of pain of 
48 months, compared to 24 months in the other group (p < 0.01).  
Changes in pain processing in the central nervous system (CNS) can occur during 
the chronic phase of neuropathic pain and sustain patients’ pain.13,18,20,22,34,35 These 
changes start to develop within hours after the initial nerve injury and take place over 
a year or more.34 Therefore, the time passed before surgical treatment of neuropathic 
pain might influence the progression of central changes and, thus, outcome.35 
If the central pain mechanism disturbances are absent, patients with neuroma 
pain of many years duration may still be improved.18,36
Previous operative procedures
Vernadakis et al.5 reported that if pain relief after the initial surgery is absent, it is 
unlikely that subsequent surgeries will be successful. Dellon and Mackinnon13 found 
a significantly worse outcome for pain in patients with three or more previous opera-
tions, compared to those treated for the first time (p < 0.01). The same result was 
found in patients with a neuroma of the RSB at a significance level of p < 0.05.27
The lower success rate in patients who had previous operations for pain may be 
partly explained by the CNS disturbances that can occur under chronic pain. Because 
these central changes cannot be easily reversed by manipulation of the peripheral 
nerve, it will be difficult to decrease pain through surgery in these patients.13 
Unexplained insuff icient pain relief
Many studies acknowledge that there is a group of patients that do not benefit from 
any form of surgical neuroma treatment. Central sensitization and psychosocial factors 
may also play a role in maintaining pain in these patients.7,13,18,21
Psychosocial factors
Psychosocial factors are seen to be an integral part of pain processing.34 Some of the 
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factors associated with poor results, for example duration of pain and unemployment, 
may initiate secondary psychosocial situations like depression.21,27
However, if exacerbated and maintained the psychological symptoms can become 
the most prominent feature.7,33 Preoperative evaluation by a psychologist is recom-
mended to identify patients with major psychopathology or functional overlay, as in 
these patients surgery is contraindicated.5,12,27 
Central nervous system changes
Although neuroma formation following injury to a peripheral nerve can cause extreme 
pain and abnormal sensitivity in the distribution of the injured nerve, not all neuromas 
are painful.4,8,11,17 The difference between asymptomatic and painful neuromas may 
either be due to the abnormal signals produced at the peripheral site or the central 
perception of these signals in the brain.11,37 
Several mechanisms are described in the literature to explain neuropathic pain after nerve 
injury. The sensory nerve endings are exposed to mechanical stimuli because of adherence of 
the neuroma to surrounding tissue or compression of the nerve endings.2,38,39 There is abnormal 
sensitivity and spontaneous activity of axons within the neuroma.37 Reduced blood supply to the 
neuroma leads to painful hypoxia of the nerve endings.2,39,40 Erratic discharges in the nerve fibers 
cause spontaneous pain. Abnormal connections between A- and C-fibers are made, causing cross-
talk of nociceptive and non-nociceptive nerve fibers, resulting in pain at touch.5,37,41
In addition to these changes at the distal site of injury, loss of normal sensory 
input may lead to a reduction of inhibitory input from afferent fibers, creating a 
state of central sensitization of neural structures involved in pain perception. With 
continued abnormal afferent input from the neuroma, there are alterations at the 
spinal cord level and in the somatosensory cortex in the processing of non-painful 
stimuli. Sensitization of spinal dorsal horn neurons and relative hypoperfusion of 
the thalamus with subsequent development of disinhibition-induced hyperexcitability 
can be found in chronic neuropathic pain patients.9,35,41-43 Chronic pain leads to an 
expansion of the cortical representation zone related to the nociceptive input.35 CNS 
changes can increase pain responses and will perpetuate the pain process even if the 
initiating peripheral injury is treated successfully.7,18,20,22,34,35 
Secondary spinal and cortical changes can be visualized using functional mag-
netic resonance imaging (fMRI) and positron emission tomography (PET) scans. 
Using these functional imaging techniques, it is possible to examine the regional cere-
bral blood flow (rCBF) associated with the regional activity in the brain. A common 
finding in patients with chronic peripheral neuropathic pain, is a decrease in rCBF in 
the thalamus contralateral to the affected limb.43,44 Decreased thalamic activity may be 
a clinical feature common to a wide variety of chronic pain disorders.9,43,45 
Another finding in the study of chronic neuropathic pain has been the observa-
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tion that children react differently to painful nerve damage. Peripheral nerve injuries 
and even limb amputations appear not to lead to chronic pain syndromes in young 
children under the age of three years.46 Consistent results have been found in young 
rats after selectively administered nerve damage.47 The lack of long-term chronic pain 
syndromes after nerve damage in neonates and young children is likely to be the result 
of CNS plasticity.46
Conclusions
By reviewing the literature, we found 14 cohort studies that mention possible prog-
nostic factors predicting insufficient pain relief after surgical neuroma treatment. 
7,12,13,15,16,18,19,21,23-28 Major prognostic factors were found to be similar among these 
studies. The factors that seem to predict the amount of postoperative pain are: neuro-
mas of the radial sensory branch (RSB) and digital nerves, discrete nerve syndrome, 
workers compensation, employment status, litigation involvement, duration of pain, 
and number of previous operations. Knowing the mechanism behind these prognostic 
factors, raises possibilities for improved treatment strategies. 
Although none of the neuroma treatment methods described in literature provide 
excellent pain relief,12-21 the application of appropriate treatment algorithms can lead 
to a satisfactory result in the majority of patients.5,11 If neuromatous pain is relieved 
by a diagnostic nerve block, surgical treatment should be performed without undue 
delay.12,34 Neuromas of the RSB and digital nerves should be placed into bone or 
large muscles without large excursions during movements.15,18,28,29 Patients receiving 
workers compensation or involved in litigation should be stimulated to redirect their 
attention away from their disability and focus on improving their performance.7,32 
Methods like transcutaneous electrical nerve stimulation (TENS), topical lidocaine 
treatment and adjuvant pain medication like antidepressants and anticonvulsants can 
have a role in neuropathic pain management.48,49
Patients suffering from painful neuroma can have an acceptable outcome after 
surgery; however, central pain disturbances can maintain pain in some patients.12,13 
These CNS changes seem to be related to the duration of pain and number of previ-
ous operations.13,35 As the CNS effects of chronic pain are profound in some patients, 
their relevance to painful nerve injuries cannot be ignored.7,12 For patients with 
central sensitization, rehabilitation programs of postoperative desensitization should 
be directed toward the re-education of non-painful stimuli. Appropriate input into 
the somatosensory cortex may alter the abnormal cortical processing.18,34,35  
Pain-related cortical reorganization should be modifiable by operant and clas-
sical conditioning processes and re-direction of attention, such as feedback-based 
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interventions.35 Mirror therapy, as described by Ramachandran and Hirstein50 has a 
potential role in sensory re-education.51 This technique has been used for the treat-
ment of hyperesthesia and pain after hand injuries in cases in which the injured hand 
cannot be touched because of excessive hypersensitivity.46,52 When touching the unaf-
fected hand, application of a mirror gives a visual illusion of touching the injured 
hand without inducing pain. Repeated training sessions seem to result in a central 
desensitization effect with reduced hypersensitivity. 
The treatment of patients suffering from neuromatous pain remains a chal-
lenge. Patient specific factors influencing prognosis after surgery should be taken 
into account. Research focusing on these prognostic factors and the central changes 
induced by painful peripheral injury can lead to new and improved clinical treatment 
algorithms for the relief and prevention of chronic neuropathic pain.9,34,43
36
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Abstract
Ultrasonography can be used in the diagnosis of various neuropathies, including nerve 
injury. Nerves that are often involved in traumatic and iatrogenic injury are small 
cutaneous nerve branches in the hand and wrist, which cannot be observed in detail 
using current clinical US devices. This validation study was conducted to explore 
the potential of high-resolution ultrasonography in visualizing these nerve branches 
in the human. The VisualSonics Vevo 770 system (15-82.5 MHz) was compared to 
a commonly used clinical US device (7-15 MHz). The accuracy was validated by 
ultrasound guided dye injection into cadaver nerves, with subsequent anatomical dis-
section and verification. Results were confirmed in two healthy volunteers. The Vevo 
770 system was able to accurately identify the small cutaneous nerves. Furthermore it 
could depict the median nerve and its fascicles in greater detail. Our findings may be 
useful for clinical diagnosis, localization and follow-up of various neuropathies and 
nerve injuries.
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Introduction
Ultrasonography (US) can be used to identify peripheral nerves. It is a non-invasive, 
cost-effective and easy to use technique. Major peripheral nerves in the extremities, 
such as the median, ulnar and radial, sciatic, common peroneal and posterior tibial 
nerves, can be visualized using conventional US performed with 7-15 MHz probes. 
US can diagnose various neuropathies, such as nerve compression in carpal 
tunnel syndrome,1,2 cubital tunnel syndrome,3,4 nerve tumours,5 and traumatic nerve 
lesions.6,7 US can be used to determine the location, extent and type of lesion, nerve 
swelling and inflammation, to identify compressive structures like calcifications and 
scar tissue surrounding the nerve and to evaluate nerves following surgery.8-11 For sur-
gically treated problems, such as injured nerves or Morton’s neuroma, it is important 
to know the exact site of the nerve lesion, before surgery. In these cases, imaging helps 
surgical excision or injection of steroids or phenol.12-15
Nerves that are often involved in traumatic and iatrogenic nerve injury are the 
superficial cutaneous branches of the median, ulnar and radial nerves in the hand and 
wrist, and the digital nerves.16-18 These sensory nerve branches are located superficial 
to the fascia just underneath the skin, making them prone to nerve damage, sometimes 
resulting in extreme pain and major disability. A painful neuroma is the most severe 
outcome of peripheral nerve injury.9
The resolution of the current clinical US equipment, with frequencies of 5-20 
MHz, does not allow adequate visualization of the small cutaneous branches of periph-
eral nerves. Therefore, this equipment may not be able to diagnose the cause of many 
nerve disorders in small subcutaneous nerve branches. By increasing the insonation 
frequency with high-resolution imaging transducers the imaging resolution improves. 
Recent advances in US imaging techniques have permitted frequencies over 80 MHz, 
with a spatial resolution down to 30 microns. These instruments can allow the imaging 
of small superficial structures. We report the use of such high resolution imaging in 
visualizing the small cutaneous nerve branches in human cadavers and volunteers.
Methods
A validation study was performed on two fresh cadaver arms, free of skin lacerations 
and without a known history of peripheral nerve pathology. The median nerve and its 
palmar branch, the sensory branch of the radial nerve, the dorsal branch of the ulnar 
nerve, and the digital nerves of the middle finger were studied. These nerves were also 
identified in vivo on the upper extremities of two healthy volunteers (approval by the 
institutional medical ethical review board, number MEC-2007-092).
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Sonographic examinations were performed using two different US devices: the 
HDI 5000 system (Philips, Amsterdam, The Netherlands) equipped with broadband 
linear array transducers and the Vevo 770 system (VisualSonics Inc., Toronto, Canada) 
equipped with broadband mechanical scanning single element transducers. The HDI 
5000 was equipped with two electronic real-time linear-array transducers (C12-7, 
C10-5) with a total range of 5-12 MHz. The Vevo 770 is a commercially available 
high-resolution US system designed for small animal research. It offers spatial resolu-
tion down to 30 microns, the highest real-time resolution currently available. The 
system was equipped with three RMV (real-time micro visualization) scanheads 
ranging from 15-82.5 MHz, with a field of view of up to 20 mm. The scanning depth 
ranged from 0 to 15 mm, depending on scanning frequency. The three scanheads used 
were no. 703, with a range of 15-49 MHz, scanning depth 4-15 mm; no. 704: 20-60 
MHz, depth 1-10 mm; and no. 708: 27.5-82.5 MHz, maximum depth 11 mm.
All US examinations were performed by a senior staff radiologist (CFvD), with 
over eight years experience in US of the musculoskeletal system. Dissection of the 
cadaver arm was performed under loupe magnification by an assistant professor in 
reconstructive surgery, with over 15 years of experience in hand surgery ( JHC). Care 
was taken to maintain the US beam perpendicular to the skin surface. A generous 
amount of US transmission gel, with air bubbles expelled, was applied to the skin to 
minimize the pressure of the transducer on the skin and to ensure a satisfactory scan. 
Nerves were located using known anatomical landmarks and were followed along 
their course distally. Scans were performed in both the transverse and longitudinal 
plane.
To subjectively evaluate the results of the difference in spatial resolution between 
the HDI 5000 system and the Vevo 770 system, images of the median nerve in the 
wrist crease were acquired with both systems. The images were compared subjectively 
on visualization and diameter measurements of (small) peripheral nerves and their 
fascicles, visualization of superficial structures and nerve sheaths and the ease of fol-
lowing the anatomical course of the nerve.
To validate the efficiency of the Vevo 770 equipment in seeing cutaneous nerve 
branches, a cadaver study was undertaken. With real-time high-resolution US guid-
ance, the tip of a 23-gauge fine needle was advanced toward the echogenic structures 
that were thought to represent the median nerve and its palmar branch, the dorsal 
branch of the ulnar nerve, the sensory branch of the radial nerve at the wrist of the 
cadaver forearm and the digital nerves. Subsequently, coloured cyanoacrylate (basic 
blue colorant dissolved in superglue) was injected through this needle into the nerves. 
The area was dissected and studied macroscopically (by JHC) to confirm the injection 
site. 
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Results
Both the HDI 5000 en de Vevo 770 systems could visualize the distal median nerve 
at the distal wrist crease as a hyperechoic structure with an internal hypoechoic fas-
cicular pattern (Fig. 1 & 2). However, due to the higher spatial resolution provided by 
the 15-49 MHz probe of the Vevo 770 system, the median nerve could be depicted in 
considerably more detail (Fig 2), making it easier to measure the size of the nerve and 
study its internal structure, the fascicles. However, because of the great magnification 
and the relatively small field of view, it was more difficult to evaluate the position of 
the nerve in relation to its surrounding structures using the high-resolution US device 
(Table 1). 
table 1: Comparison of a standard and high-end US device in the visualization of periph-
eral nerves in the human. 
US: ultrasound; ++: excellent visualization; +: good visualization; 0: poor visualization
Also the palmar cutaneous branch of the median, radial sensory, dorsal ulnar 
and digital nerves could be visualized using the 15-82.5 MHz probes of the Vevo 770 
device. Validation has been performed by JHC after injecting coloured cyanoacrylate 
under US guidance (Fig 3) in the respective nerves and subsequent anatomical dissec-
tion to verify the structure seen. At macroscopic examination of the nerve structures 
in the cadaver arm, the injected dye was found in all studied nerves. This confirms the 
accuracy of our observations   
Using the Vevo 770 system, all peripheral nerves under study were seen as echo-
genic oval to round structures with a honeycomb structure on transverse scans. A 
hyperechoic rim of connective tissue surrounded the nerves. Hypoechoic fascicles could 
be seen inside the nerve, ranging from only four fascicles in the smallest nerves, to 
around a dozen in the median nerve. On longitudinal scans the nerves were composed 
of multiple hypoechoic and parallel linear areas separated by hyperechoic bands.
Standard
US device
High-end
US device
Visualization of major peripheral nerves ++ ++
Diameter measurements of large peripheral nerves ++ ++
Visualization and measurements of fascicles + ++
Visualization of small peripheral nerves 0/+ ++
Diameter measurements of small peripheral nerves 0/+ ++
Visualization of nerve sheaths + ++
Following the anatomical course of the nerve ++ +
Visualization of superficial structures + ++
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figure 2. 15–49 MHz US image of the median nerve. 
Both images made 8 cm proximal to the wrist crease
figure 1. 5–10 MHz US image of the median nerve  
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With the 5-12 MHz US larger nerves, i.e. median nerve, could be visualized 
well, however, smaller cutaneous nerves, i.e. dorsal branch of the ulnar nerve or palmar 
branch of the median nerve, could not be detected.
Applicability of the standard and high-end US devices in visualizing peripheral 
nerves was also confirmed in two healthy volunteers. By repeating our work without 
the dye injection and subsequent dissection, small nerve structures could only be 
observed in detail using high-end US (Fig 4 & 5). Overall, compared to the cadaver 
arms, the capture of nerve structures seemed easier in living subjects. This is probably 
due to the improved visualization of blood-vessels that often accompany the nerve.6
figure 3. US guided injection of coloured cyanoacrylate into the median nerve. 
Left arrow indicates tip of the needle.
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figure 4. US image (5–10 MHz) of the middle finger palmar digital nerve 
(left arrow) and digital artery (right arrow).
figure 5. US image (20–60 MHz) of the middle finger palmar digital nerve (left arrows) 
and digital artery (right arrows).
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Discussion
The present study was conducted to explore the use of a high-resolution US device 
(VisualSonics Vevo 770) in the imaging of small superficial peripheral nerves. All 
investigated nerves could be visualized using the high frequency probes of the device. 
Although US is used for major peripheral nerves,1-4,9,11 US visualization of the smaller 
sensory branch of the radial nerve, palmar branch of the median nerve and dorsal 
branch of the ulnar nerve may be helpful in making a diagnosis, in finding the exact 
location and in grading the severity of entrapment, nerve injury and possibly neu-
ropathic pain.8,10,11,14,15,19 In traumatic or iatrogenic nerve injury, high-resolution US 
could discriminate between partial or full injury and help in surgical planning.9 Also, it 
could be used to monitor nerves treated conservatively to assess regenerating nerves.
When following the anatomical course of a nerve, high-resolution US has some 
limitations due to its restricted field of focus. Different probes are needed to follow 
the course of a nerve especially when its anatomical localization becomes deeper. By 
increasing the frequency, the pulse length decreases, this makes the waves less capable 
of penetrating deeper tissues. US in clinical use has reached frequencies of 20 MHz 
at present and frequency and resolution are steadily increasing.
The US Vevo 770 equipment was developed for research in small animals where 
the drawback of the decreased penetration depth is of lesser importance. However, 
high frequency transducers have already been used for various clinical applications, 
such as dermatological and intravascular imaging.20
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Abstract
Purpose: 
Cold intolerance imposes great changes on patients’ life-style, work and leisure activi-
ties and is often severely disabling. This study aims to investigate the prevalence and 
severity of cold intolerance in patients with traumatic neuromas of the upper extrem-
ity and improvement of symptoms after surgical treatment. Furthermore, we try to 
find predictors for cold intolerance and correlations with other symptoms.
Methods: 
Between January 2006 and February 2009, 34 consecutive patients with surgically 
treated neuroma specific neuropathic pain of the upper extremities, were sent a ques-
tionnaire composed of both general questions concerning epidemiologic determinants 
and several specific validated questionnaires, including the Visual Analogue Scale 
(VAS) for pain. To objectively estimate the prevalence of cold intolerance in neuroma 
patients, we used the validated CISS (Cold Intolerance Symptom Severity) question-
naire with a pre-specified cut-off point.
Results: 
The CISS questionnaire was filled out by 33 patients before and 31 after surgery, with 
a mean follow up time of 24 months. We found a prevalence of cold intolerance of 
91% before surgery, with a mean CISS score high above the cut-off point for abnor-
mal cold intolerance and a prevalence of 77% after surgery. The mean CISS score 
decreased only mildly, while the mean VAS score decreased significantly after surgery 
(p<0.01). CISS scores were lower in patients with a sharp injury of the peripheral 
nerve (p=0.02). A higher VAS score correlated significantly with a higher CISS score 
(p=0.01).
Conclusions: 
Cold intolerance is a difficult and persistent problem that has a high prevalence in 
patients with a painful traumatic neuroma. There seems to be a relation between 
severity of cold intolerance and spontaneous pain and type of injury. It is unlikely that 
cold intolerance disappears with time or surgical treatment.
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Introduction
Cold intolerance is defined as abnormal pain of the hand and fingers after exposure to 
mild or moderate cold, with or without discoloration, numbness, weakness or stiffness. 
It is also known as thermal hyperalgesia or cold sensitivity and affects all work and 
leisure activities taking place outdoors or in moderate cold. Therefore, cold intolerance 
may seriously influence patients’ daily life.1,2 Cold intolerance is a common long-term 
sequel following upper extremity injury, with an estimated incidence of 42 - 100%.3-6
When a peripheral nerve is damaged, it will try to regenerate itself toward the 
distal nerve end or target organ.7 If a distal target is not found, axon sprouts may grow 
into the surrounding scar tissue forming a neuroma.8-10 Some of these neuromas cause 
intense pain and altered sensation in the distribution of the injured nerve.11 Once 
a neuroma has formed, best results are usually obtained from surgical intervention, 
usually by relocation of the nerve end into muscle or bone.11,12 A high incidence of 
cold intolerance is to be expected in neuroma patients. However, there is no data 
available on the prevalence of cold intolerance in patients with a painful traumatic 
neuroma. The extent of this problem is currently unknown. 
Most studies focusing on peripheral nerve injuries have estimated the prevalence 
of cold intolerance using only subjective symptoms mentioned by patients.3,13 They 
also did not specify the variable used to measure cold intolerance.14 To objectively 
estimate the incidence of cold intolerance in neuroma patients, we used the validated 
CISS (Cold Intolerance Symptom Severity) questionnaire with a pre-specified cut-off 
point. In addition, we follow the surgically treated neuroma patients to see how their 
pain and cold intolerance symptoms change post-operatively and investigate the rela-
tionship between these two problems. 
This study aims to investigate the prevalence and severity of cold intolerance in 
patients with traumatic neuromas of the upper extremity and improvement of symp-
toms after surgical neuroma treatment. Furthermore, we try to find predictors for cold 
intolerance and correlations with other symptoms.
Materials and methods
Study design
Between January 2006 and February 2009, we performed a prospective cohort study 
on surgically treated neuroma patients. Intake questionnaires were sent prior to 
surgery. This questionnaire contained both general questions concerning epidemio-
logic determinants and several specific validated questionnaires on pain, loss of upper 
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extremity function, symptoms of psychopathology and cold intolerance. Follow-up 
questionnaires concerning cold intolerance and pain were sent in February 2009, to 
all included patients with a follow-up period of at least 3 months.
Study population
Entry criteria were patients diagnosed with neuroma pain, planned for surgical 
neuroma treatment by author JHC in or institution. 34 consecutive patients, with 
neuroma specific neuropathic pain of the upper extremities, were asked to participate 
in our study. 
The diagnosis neuroma specific neuropathic pain was made based on history and 
complaints, presence of Tinel’s sign and reduction of pain after nerve blockade. The 
surgery entailed excision of the neuroma with relocation of the nerve end into muscle 
or bone. After obtaining their consent, the patients were sent an initial questionnaire 
when they were scheduled for surgery and another questionnaire at least 3 months 
post operatively. Non-responders were contacted by telephone and requested to return 
the questionnaire. This study was approved by the Medical Ethics Committee of our 
institution.
Scoring methods
The pre-operative questionnaire contained questions concerning patient specific 
factors such as age, gender, length, weight, smoking status, dominant hand affected, 
employment status, workers compensation, pending litigation, type of injury and 
number of previous operations. 
The severity of post-traumatic cold intolerance was measured using the self-
administered Blond McIndoe Cold Intolerance Symptom Severity (CISS) question-
naire, which has been validated in both a peripheral nerve injury group and a normative 
control group.6,15The CISS questionnaire is used to measure self-reported symptoms 
of CI and consists of 6 questions (table 1). The first question involves the occurrence 
of the following symptoms and signs: pain, numbness, stiffness, swelling and skin 
color change into white or blue. According to the official score guidelines, answers to 
this first question are not calculated towards the final CISS score. Questions two to 
six relate to the frequency, duration, severity and impact of cold intolerance symptoms 
on activities of daily live. Question 5 consists of the earlier McCabe Cold Sensitivity 
Test.4,16,17 The CISS questionnaire was translated into Dutch, following the recom-
mendations for the cross-cultural adaptation of health status measures, supported by 
the American Academy of Orthopaedic Surgeons (AAOS) and the Institute for Work 
& Health (IWH). The CISS questionnaire gives a minimum score of 4 and a maxi-
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table 1. The CISS Questionnaire, by Irwin et al.6
Question # Score
1. Which of the following symptoms do you experience in your injured limb on exposure to cold?*
Pain; numbness; stiffness; swelling; blue or white skin color 
change
-
2. How often do you experience these symptoms? (please tick)
Continuously/ all the time
Several times a day
Once a day
Once a week
Once a month or less
10
8
6
4
2
3. When you develop cold induced symptoms, on your return to a warm environment are the 
symptoms relieved (please tick):
Within a few minutes
Within 30 minutes
After more than 30 minutes
2
6
10
4. What do you do to ease or prevent your symptoms occurring? (please tick)
Take no special action
Keep hand in pocket
Wear gloves in cold weather
Wear gloves all the time
Avoid cold weather/stay indoors
Other (please specify)
0
2
4
6
8
10
5. How much does cold bother your injured hand in the following situations (please score 
0-10):
Holding a glass of ice water**
Holding a frozen package from the freezer**
Washing in cold water**
When you get out of a hot bath/shower with air at room 
temperature**
During cold winter weather
10
10
10
10
10
6. Please state how each of the following activities have been affected as a consequence of cold 
induced symptoms in your injured hand and score each (please score 0-4):
Domestic chores
Hobbies and interests
Dressing and undressing
Tying your shoe-laces
Your job
4
4
4
4
4
* The answers given in this question do not count towards the f inal CISS test-score.
** These are the questions from the McCabe Cold Sensitivity Test. 
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mum score of 100. 
The visual analogue scale (VAS) consists of a horizontal line of 10 cm, anchored 
with the words ‘no pain at all’ on the left side and ‘unbearable pain’ on the right. The 
patient has to place an x on the line representing the amount of pain felt. The VAS 
score ranges from 0 to 10. Additionally, four questions concerning the severity of 
different types of pain were asked. The types were: spontaneous pain, pain on pressure, 
pain on movement and painful hyperesthesia on light skin touch. The severity of the 
pain was scored as severe, moderate, mild or absent.
The disabilities of the arm, shoulder and hand (DASH) questionnaire is a 
self-administered outcome instrument developed as a measure of self-rated upper 
extremity disability and symptoms. It is the most widely used upper extremity-specific 
health-status measure.18 The DASH consists mainly of a 30-item disability scale, 
scored 0 (no disability) to 100 (most severe disability). In this study we used the 
approved Dutch version of the DASH.19
Duration of pain was defined as time between the development of neuroma pain 
and surgery and follow-up as time since surgery in months.
Statistical methods
Patient and injury characteristics were tested for association with the pre-operative 
CISS score using Pearson’s Correlation test for continuous variables. Analysis of vari-
ance (ANOVA) and (paired) t-tests were used to compare categorical variables. The 
z-test was used to compare proportions. All tests were two sided and a p-value of less 
than 0.05 was considered statistically significant. All data analyses were performed 
using Statistical Package for the Social Sciences (SPSS, Chicago, Illinois, USA), 
version 16.0. 
Results
Study population
Between January 2006 and February 2009, 34 patients returned the intake ques-
tionnaire, approximately 4 weeks before surgery. All 34 patients were operated with 
excision of the neuroma and relocation of the nerve end into muscle or bone. One 
patient filled out the pre-operative questionnaire incorrectly; she was excluded from 
our study. The follow up questionnaire was sent to 32 patients; excluding one patient 
from post-operative analyses, which had had surgery less than 3 months ago. The 
follow-up questionnaire was returned by 30 patients, 2 patients did not want to coop-
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erate. Demographics of the 33 included neuroma patients are presented in table 2. 
The study population consists of 18 males and 15 females, with an average age of 
43 years on the day of filling out the first questionnaire. The mean duration of pain 
was 42 months. In 76% of the cases the dominant hand was affected. Types of injury 
included 18 (54%) sharp lacerations, 9 (27%) crush injuries, 5 (15%) avulsion injuries 
and 1 (3%) had an unknown cause. Nine patients (27%) had a (partial) digital amputa-
tion. After surgical treatment, 12 patients required secondary procedures for their 
pain problem.
Outcome variables
Pain was the most frequent cold-induced symptom in neuroma patients, indicated by 
85% of the participants before surgery (table 1, question 1). Numbness was present 
in 21% of the neuroma patients. Other signs were stiffness (42%), skin color change 
(21%) and swelling (6%). Six percent of patients reported no signs or symptoms of 
cold intolerance prior to surgery. Most of these signs and symptoms were mentioned 
less frequent after surgery (table 3). The mean total CISS score of questions 2 to 
table 2: Characteristics of responding neuroma patients (n=33)
Characteristic
Age (years) mean
range
43 (SD 14)
17 - 75
Gender male
female
18 (55%)
15 (45%)
Injured nerve digital 
radial sensory branch
LABCN
ulnar 
17 (52%)
12 (36%)
3 (9%)
1 (3%)
Dominant hand affected yes
no
25 (76%)
8 (24%)
Lesion sharp
crush
avulsion
unknown
18 (54%)
9 (27%)
5 (15%)
1 (3%)
Duration (months) mean
range
42 (SD 36)
5 – 142
Follow-up (months) (n=31) mean
range
24 (SD 13)
3 – 47
SD: standard deviation; LABCN: lateral antebrachial cutaneous nerve
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6 was 54 (SD 20) prior to surgery, with a minimum of 6 and a maximum of 84. 
Thirty patients (91%) exceeded the standardized cut-off point (CISS score of 30) for 
abnormal cold intolerance.15 After an average of 24 months follow-up, the percentage 
of patients with cold intolerance was 77%, this decrease was not significant (z-test). 
4 patients, who had significant symptoms of cold intolerance before surgery, did not 
have a significant score on the CISS questionnaire averagely 39 months after surgery. 
Overall, the mean CISS score decreased only mildly (52, SD 31). The mean VAS 
score decreased significantly from 6.6 to 4.5 after surgery (paired t-test, p<0.01).
Using ANOVA we found no statistical difference in CISS-scores between 
the different affected nerves. We found no significant correlation between CISS 
and duration of pain or follow-up time. Other non-significant predictors for CISS 
score were: age, gender, smoking status, dominant hand affected, employment status, 
workers compensation and pending litigation (data not shown). Number of previous 
operations was not correlated to CISS score, nor was the mean CISS score different 
for patients with or without secondary procedures.
VAS score was positively correlated (p=0.01) and to CISS score. The DASH 
score showed a significant positive correlation with CISS score, but controlled for 
VAS score, this correlation was no longer significant. Performing a t-test on type of 
injury, we found a statistically significant lower mean CISS score for sharp injuries 
compared to other types of injuries (p=0.02).
Discussion
The present study was conducted to evaluate the prevalence and severity of cold 
intolerance in patients with neuroma pain. Using the CISS questionnaire we found 
an pre-operative prevalence of 91%, with a mean CISS score high above the cut-off 
point of 30, for abnormal cold intolerance.15 The mean CISS score and prevalence of 
cold intolerance did not significantly decrease after surgical neuroma treatment. Cold 
intolerance was lower in patients with a sharp injury of the peripheral nerve. A higher 
subjective pain score (VAS) correlated significantly with a higher CISS score.
To our knowledge, literature relating to cold intolerance in neuroma patients is 
sparse. Therefore, our data will be put into perspective using literature on peripheral 
nerve injury in general. A high incidence of post-traumatic cold intolerance in the 
upper extremity has been reported by several authors.3-5,14,20-22 Most studies in this 
field describe the incidence of cold intolerance following peripheral nerve injury or 
amputation and after replantation of digits. Our study is the first to look at the preva-
lence of cold intolerance in patients that have been operated for painful nerves after 
an injury. The obtained mean CISS score of 54 in our study population is significantly
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table 3. Results of validated questionnaires
SD: standard deviation; CISS: Cold Intolerance Severity Scale, range 4-100, where 100: most severe 
cold intolerance, cut-off point for abnormal cold intolerance is 30. DASH: Disability of Arm Shoulder 
and Hand, range 0-100, where 0: no disability and 100: most severe disability. VAS: Visual Analogue 
Scale, scale 0-10, where 0: no pain at all and 10: unbearable pain.
**: signif icant difference between pre- and post-operative value, with p<0.01.
table 4. Influence of continuous variables on CISS score (Pearson’s correlation coefficient)
VAS: Visual Analogue Scale. DASH: Disability of Arm Shoulder and Hand. BMI: Body Mass 
Index
* = p-value signif icant at the 0.05 level.
** = p-value signif icant at the 0.01 level
Variable Pre-operative Post-operative
CISS score
Pain
Numbness
Stiffness
Color changes
Swelling
No complaints
54 (SD 20)
85%
21%
42%
21%
6%
6%
52 (SD 31)
67%
30%
40%
30%
3%
13%
Patients with cold intolerance (CISS > 30) 30 (91%) 23 (77%)
DASH score 50 (SD 22) 41 (SD 24)
VAS score 6.6 (SD 2.3) 4.5 (SD 3.2)**
Variable Correlation Coefficient (r) p-value
VAS pre-operative 0.443 0.010**
BMI -0.349 0.046*
DASH
  Controlled for VAS
0.438
0.258
0.011*
0.155
Duration of pain (months) 0.033 0.856
Follow-up (months) -0.260 0.165
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higher than scores obtained in other types of nerve injury patients.6,23 In a study by 
Ruijs et al.,23 a mean CISS score of 38 was found for median and ulnar nerve injuries, 
with 59% of the 107 subjects being classified as having cold intolerance. Irwin et al.6 
found a mean CISS score of 41 in 398 patients with upper extremity nerve injuries.
The estimated prevalence of cold intolerance, as reported in literature, largely 
depends on the method of measuring and defining cold intolerance.13,20 In literature, 
this classification ranges from subjective symptoms mentioned by patients,3,13 to the 
use of a validated questionnaire.6,23 Some articles do not even specify the variable used 
to measure cold intolerance,14 or do not describe any cut-off point for abnormal intol-
erance of cold or validation of the method used.24 In our study, we used the validated 
CISS questionnaire with a specified cut-off point. In contrast to VAS pain score, the 
mean CISS score and percentage of patients identified as experiencing above normal 
cold intolerance, did not significantly decrease after surgery. Similar results have been 
reported in literature: these studies tested patients multiple times and found that, 
despite an improvement of symptoms, cold intolerance did not disappear.4,5,21,22 Our 
results are illustrative of the severe and persistent nature of post-traumatic cold intol-
erance and they show that little or no benefit can be gained from surgery.
There was no significant relationship between duration of pain or follow-up time 
and CISS score, which implies that cold intolerance is independent of time between 
injury or surgery, and the time that has elapsed after treatment. This is supported by 
other studies that found cold intolerance unlikely to disappear with time.5,6,20,21,23,25-27
Pain was the most frequent cold-induced symptom in our study population. This 
is a common finding in literature where pain is often mentioned as the most trouble-
some symptom of cold intolerance.24,28 Although smoking is known to impair digital 
bloodflow and wound healing in the hand,29,30 a relation between smoking and cold 
intolerance could was not observed.4,26
Our data showed a significantly lower CISS score in patients with a sharp injury, 
compared to other types of injuries. This finding is consistent with the finding of Irwin 
et al.,6 demonstrating that sharp injuries are less likely to be associated with the sever-
ity cold intolerance. They may lead to a larger chance of a successful revascularization 
and replantation of amputated digits than do crush or avulsion type injuries.6,21,31,32 An 
explanation for the higher CISS score in patients with an avulsion or crush injury may 
be the fact that adequate coaptation of the nerve ends is nearly impossible. This may 
cause several “micro-neuromas” at different levels. Another cause for the increased 
CISS score in these injuries is the greater extent of the zone of nerve injury.
Painful neuromas of the peripheral nerves may occur after (partial) nerve damage. 
Patients with a painful traumatic neuroma display intense pain, altered sensation, 
mechanical hyperalgesia and cold intolerance in the distribution of the injured nerve. 
Little is known about mechanisms of cold intolerance.33 In normal situations, lower-
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ing skin temperature evokes a painless cold sensation, which will ultimately become 
a cold and painful sensation after further cooling. In cold intolerant patients this 
process is disturbed. 
Cold sensation is mediated by small myelinated A-delta fibers and cold induced 
pain by unmyelinated C-nociceptors. The combination of the two inputs results in 
the blended sensation of cold and usually aching pain. In a neuroma, abnormal con-
nections between A- and C-fibers are made, causing “cross-talk” between nociceptive 
and non-nociceptive nerve fibers, resulting in mechanical and thermal hyperalgesia. 
There is abnormal sensitivity and spontaneous activity of injured axons, caused by 
sensitized C-nociceptors.16,34-38 In addition, loss of afferent A-fiber input may lead to 
disinhibition, creating a state of central sensitization of neural structures involved in 
pain perception.39-41 
These mechanisms possibly explain the significant correlation between cold 
intolerance and subjective pain experience in neuroma patients: sensitized nociceptive 
C afferents in neuroma patients display exaggerated and unmodulated signals of pain 
after mild exposure to cold. In addition they may also fire without this exposure, 
leading to spontaneous pain. The central nervous system changes do not seem to 
disappear in time or with surgical treatment, which may explain why CISS scores did 
not decrease in our study population.
This study was conducted to look at the prevalence of cold intolerance in patients 
with a neuroma of the upper extremity and improvement of symptoms after surgi-
cal treatment. Cold intolerance is a difficult problem that has a high prevalence in 
patients with a painful traumatic neuroma. Cold intolerance was observed to be less 
common after sharp injuries compared to other types of injury. We observed a relation 
between severity of cold intolerance and subjective spontaneous pain and it is unlikely 
that cold intolerance disappears with time or surgical treatment. 
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Chapter 5:
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radial ner ve
 
The unforgiving nerve: treatment strategies for neuropathic pain caused by the superf icial 
branch of the radial nerve. Stokvis A, Coert JH. Under review for The Journal of Hand 
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Abstract
Purpose: 
Neuropathic pain in the upper extremity can cause extreme disability, often leading to 
workers compensation and high health care expenditures. The sensitivity of the super-
ficial branch of the radial nerve (SBRN) for the development of neuropathic pain is 
well documented, and achieving satisfactory pain relief remains extremely difficult. 
This study was performed to evaluate different treatment strategies for neuralgias 
caused by direct injury to the SBRN on the dorsum of the wrist. 
Methods: 
Surgical records were searched for patients with SBRN neuralgia. Data were col-
lected from medical files. The effect of a pre-operative diagnostic nerve block was 
determined. Study outcomes were patient satisfaction and pre- vs. post-operative pain 
decrease scored with the numerical rating scale (NRS). Patient satisfaction follow-
ing neurolysis, nerve reconstruction, denervation and adjacent nerve neurectomies 
was evaluated, and different relocations of the SBRN end were compared. Forty-nine 
patients were included. Thirty-one patients underwent external neurolysis of the 
SBRN. In five patients the nerve was reconstructed and 38 patients underwent den-
ervations of the SBRN. Eighteen patients underwent neurectomies of adjacent nerves, 
including the posterior interosseous nerve (PIN) and lateral antebrachial cutaneous 
nerve (LABCN).
Results: 
In total, 29 patients achieved satisfactory results (59%). The median NRS pain score 
decreased from 7.5 to 2.5 (p<0.001). Operations relocating the SBRN into the brachi-
oradial muscle achieved significantly higher patient satisfaction rates than relocation 
of the nerve end elsewhere (p=0.04). PIN and LABCN neurectomies also provided 
satisfactory pain relief. A lower NRS pain score decrease and lower satisfaction rates 
were found in patients with an unsuccessful diagnostic nerve block.
Conclusions: 
When treating traumatic SBRN neuralgias, there are several effective treatment 
methods, depending on the continuity of the injured nerve and the involvement of 
adjacent nerves. In case of an end-neuroma of the SBRN, relocation of the nerve end 
into the brachioradial muscle should be performed. 
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Introduction
Neuropathic pain in the upper extremity following peripheral nerve injury is a serious 
problem, commonly involving relatively young patients.1 The pain causes loss of func-
tion and productivity, changes patients’ life-style, and can progress into a chronic 
pain syndrome that can be severely disabling.2 This leads to high unemployment and 
workers compensation rates with considerable costs to society,3 as well as high health 
care expenditures.4
Neuropathic pain caused by lesions or perineural adhesions of the superficial 
branch of the radial nerve (SBRN), remains one of the most difficult conditions for 
which to achieve satisfactory pain relief,5,6 and provides a good example for the prob-
lematic treatment of peripheral neuropathic pain. The SBRN supplies sensation to 
the dorsolateral hand and the dorsal aspects of the first three fingers, and can easily be 
injured following trauma or surgical procedures, because of its superficial location.7,8 
After peripheral nerve damage, axon sprouts grow into the surrounding scar tissue 
forming a neuroma,9 this often causes sensory deficits, areas of skin dysesthesia, and 
severe pain.8,10
Treatment options for this peripheral nerve problem are primarily surgical. 
Despite improving techniques for complete denervation of the SBRN, many patients 
suffer from recurrent pain and mechanical hyperalgesia in the operated area. There 
is increasing evidence that hyperalgesia is independent of spontaneous pain originat-
ing in the peripheral neuroma.11-14 This suggests changes in neighboring intact nerve 
fibers,13 recruitment of axons from adjacent nerves,11,15 or direct injury to surround-
ing nerve branches.16,17 Apart from surgical treatment, therapeutic options are largely 
limited to symptom control, including pharmacologic treatment, nerve stimulators or 
temporary nerve blocks.4,14
This study was conducted to evaluate patient satisfaction following different sur-
gical treatment methods for SBRN neuralgia caused by lesions or adhesions of directly 
traumatized superficial branches of the radial nerve (SBRN), including neurolysis, 
nerve reconstruction, denervation and adjacent nerve neurectomies. Different reloca-
tions of the SBRN end were compared and the prognostic value of a pre-operative 
diagnostic nerve block and patient specific determinants was explored. 
Materials and Methods
We performed a retrospective cohort study, to evaluate the different treatment strat-
egies for SBRN neuralgia caused by direct injury to the superficial branch of the 
radial nerve. Surgical records were searched for procedures involving neuropathic pain 
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caused by the SBRN, performed or supervised by the senior author between March 
2001 and May 2009. Patients with traumatic nerve lesions or perineural adhesions 
of the SBRN in the dorsoradial hand or wrist were included. Patients with SBRN 
entrapment between the tendons of the brachioradialis and extensor carpi radialis 
longus (Wartenberg syndrome), were excluded, as well as proximal entrapments of the 
radial nerve in the upper extremity. 
We found 56 patients who underwent relevant surgical procedures of the SBRN. 
Seven patients were excluded. Four of these patients were treated for Wartenberg neu-
ropathy, one had an injury of the radial nerve in the elbow, and two patients underwent 
nerve repair or neurolysis for loss of sensibility after injury, without complaints of pain 
or dysesthesia. Characteristics of the 49 included patients are presented in table 1. 
The study population consisted of 17 males and 32 females, with an average age of 40 
years. The mean duration of pain was 30 months. Six patients had undergone previous 
operative procedures for their pain problem in other medical centers. 
Types of injury included 44 (90%) sharp lacerations, two (4%) crush injuries, two 
(4%) avulsion injuries, and one (2%) unknown cause. An iatrogenic cause was present 
in 82% of patients, mainly concerning surgical De Quervain’s release (table 2). Follow 
up time varied between three and 99 months, with an average of 41 months.
 
table 1. Patient characteristics (n=49) 
Characteristic N
Sex male
female
17
32
Age (years)
  
mean
range
40 (SD 12)
16–63
Injury sharp
crush  
avulsion
unknown
44
2
2
1
Iatrogenic injury 40
Dominant side affected 30
Amputation 2
Duration of pain (months) mean
range
30 (SD 41)
2 – 222
Duration of pain <12 months
>12 months
17
32
Follow up (months) mean
range
41 (SD 24)
3 – 99
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Patients were diagnosed on the base of their symptoms, history, and clinical 
assessment. Symptoms suggestive of SBRN adhesions or injury consist of electric 
pain in the dorsoradial wrist or hand, with a history of with a past history of a skin 
laceration or incision in the dorsoradial wrist area.8 Clinical assessment showed a 
positive Tinel’s sign: shooting pain after percussion on the nerve. In most cases, a 
diagnostic nerve block with 1% lidocaine was performed to evaluate possible overlap 
of neighboring nerves contributing to the pain problem,16 and to identify the pres-
ence of central sensitization processes or phantom limb pain.8,16,22 It is assumed that 
if the pain diminishes, surgery will be effective in providing pain relief.22 Absence of 
relief after anesthetic block can be interpreted as a contraindication to surgery8 and 
patients without a decrease or even an increase of their symptoms are excluded from 
operation. 
Information on treatment strategy and surgical techniques was collected from 
surgical reports. Patients suffering from SBRN neuralgia often undergo multiple sur-
gical procedures in order to achieve satisfactory pain relief. Patients were treated using 
various techniques proposed in the literature.5,9,10,16,23 A flow chart of the treatment 
strategy that was used is presented in figure 1. All procedures included in this study 
were performed or supervised by the same hand surgeon. 
Thirty-one patients that presented with perineural adhesions of the SBRN were 
primarily treated by external neurolysis.5 In case of a painful neuroma, the neuroma 
was excised and in five patients continuity could be restored, in some cases using a 
neurotube or nerve graft.23 If nerve repair was not possible, denervation of the SBRN 
was performed with relocation of the nerve end into bone,24 muscle,8,16,23 a silicon 
table 2. Iatrogenic causes of neuralgia (n=40)
Surgical procedure Number of 
patients
%
De Quervain’s release 14 35%
Joint (arthrodesis, arthroplasty) 6 15%
Ganglion excision 4 10%
Ligament (SL, Eaton-Littler, UCL) 4 10%
CTS release 3 8%
Tendon, other (tenolysis, transfer) 3 8%
Bone (sequestrotomy, osteotomy) 3 8%
Flap (RFF, TE) 2 5%
Debridement 1 3%
SL: scaphoid-lunate; UCL: ulnar collateral ligament; CTS: carpal tunnel 
syndrome; RFF: radial forearm flap; TE: tissue expander.
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nerve sheath or an end-to-side nerve loop.10 Twenty patients underwent denervation 
of the SBRN with relocation of the nerve end into the BR muscle (figures 2–4). In 18 
patients the nerve end was relocated elsewhere. 
In case of recurrent or persistent pain following SBRN denervation, neurectomies 
of adjacent nerves suspected of transmitting pain signals were performed. Nerves that 
often lie in proximity to the SBRN injury site are the lateral antebrachial cutaneous 
nerve (LABCN), posterior interosseous nerve (PIN), palmar branch of the median 
nerve (PBMN), anterior interosseous nerve (AIN) and the radial digital nerve of the 
thumb. Eighteen patients underwent surgical procedures of neighboring nerves in the 
dorsoradial wrist area.
Patient follow up data were obtained from outpatient clinic records that were 
available for all included patients. The primary outcome was patient satisfaction 
was scored in four categories: excellent, satisfactory, unsatisfactory, and extremely 
unsatisfactory; as well as a total satisfaction rate. Patients were classified according 
to their pain reduction, dysesthesia relief, and the necessity of further (surgical or 
anesthetic) pain treatment judged by the attending hand surgeon at the outpatient 
clinic: ‘Excellent’: patient reported extreme satisfaction with treatment result; or all 
symptoms of pain and hyperalgesia had disappeared. ‘Satisfactory’: patient reported 
satisfaction; or pain and hyperalgesia decreased to a bearable level. ‘Unsatisfactory’: 
figure 1. Flow chart of treatment strategy for neuropathic pain caused by 
the superficial branch of the radial nerve 
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figureS 2-4. Surgical denervation, with relocation of the superficial branch of the radial 
nerve into the brachioradial muscle
Photos: AVD Erasmus MC. Printed with patient’s permission
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patient reported to be dissatisfied; or minimal decrease in pain and/or hyperalgesia 
without indication for re-operation. ‘Extremely unsatisfactory’: patient reported to be 
extremely dissatisfied; or minimal/no decrease or increase in pain and hyperalgesia, 
indication for re-operation. 
Pain (decrease) scored with the numerical rating scale (NRS), was a secondary 
outcome.25 Patients were asked to rate their pain as any number between 0, ‘no pain 
at all’, and 10, ‘unbearable pain’ pre- and post-operatively. Pre- and post-operative 
NRS pain scores were available for respectively 21 and 41 patients. Information on 
demographic factors, etiology, type of lesion, duration of pain, and previous surgical 
procedures were collected from medical files. 
In a secondary analysis including 28 patients, we studied the prognostic value 
of the pre-operative diagnostic SBRN block. The effect of the diagnostic nerve block 
was attained using pre- and block NRS pain scores, which were recorded at the out-
patient clinic before surgery. We determined a cutoff value of at least 3.5 points pain 
reduction on the NRS for good nerve block effect. 
The study has been approved by our institutional medical ethical review board 
(number MEC-2007-094).
Statistical methods
To evaluate different treatment strategies, we calculated satisfaction rates for all types 
of surgical procedures performed, analyzing only one surgical procedure per patient. 
For denervations of the SBRN, we compared patient satisfaction following primary 
surgical procedures, relocating the nerve the nerve end into the brachioradial muscle, 
or elsewhere. Post-operative satisfaction for these procedures was compared using the 
Kruskal-Wallis test. Possible confounders were tested on their distribution among 
treatment groups. Independent t-tests were used to compare continuous variables and 
paired t-tests for repeated measurements. 
NRS pain score decrease and satisfaction rates were compared between patients 
with and without an effective diagnostic nerve block. We compared patient character-
istics and outcomes (age, sex, duration of pain, number of previous operations, post-
operative pain and satisfaction) among the groups with and without available nerve 
block outcomes. The Mann-Whitney U test was used to compare ordinal (NRS score 
decrease and patient satisfaction) data among groups, and the Wilcoxon signed-rank 
test for comparison of paired data ordinal data, including the pre- and post-operative 
NRS pain scores. 
All tests were two sided and a p-value of less than 0.05 was considered statisti-
cally significant. All data analyses were performed using Statistical Package for the 
Social Sciences (SPSS, Chicago, Illinois, USA), version 16.0.
73
The ‘unforgiving’ superficial branch of the radial nerve 
table 3. Patient outcomes (n=49)
Outcome N
Number of operations
    1
    2
    >3
21
14
14
>1 operation: 57%
Patient satisfaction
    Extremely satisfied
    Satisfied
    Unsatisfied
    Extremely unsatisfied
20
9
12
8
Satisfied: 59%
Unsatisfied: 41%
Median NRS pain score (range)
    Before surgical treatment
    Following surgical treatment
21
41
7.5 (2.5 – 9.0)
2.5 (0.0 – 10)*
* Wilcoxon signed-rank test (n=21) for pre- and post-operative NRS pain score: p<0.001
Results
Surgical results were excellent in 20 patients, satisfactory in nine, unsatisfactory in 
12, and extremely unsatisfactory in eight patients (table 3). The median NRS pain 
score decreased from 7.5 to 2.5 after surgical treatment (Wilcoxon signed-rank test, 
p<0.001). Patient satisfaction varied between different treatment methods as presented 
in tables 4 and 5. Operations relocating the SBRN into the BR muscle achieved a 
satisfaction rate of 45%; this was 11% with relocation of the nerve end elsewhere. 
SBRN neurolyses showed a satisfaction rate of 39%. This was 55% and 50% for PIN 
and LABCN neurectomies respectively. 
Satisfaction rates of primary surgical procedures for SBRN end-neuromas were 
compared; the results are displayed in table 6. Average duration of pain, number of 
patients with pain duration over 12 months, median pre-operative NRS pain score 
and number of previous surgeries were evenly distributed among the two treatment 
groups. Denervation with relocation of the nerve end into the BR muscle was signifi-
cantly more effective in providing satisfactory pain relief than relocation elsewhere 
(p=0.03). None of the patients primarily operated by nerve repair or relocation of the 
SBRN elsewhere achieved satisfactory pain relief after surgery. 
Patients with at least 12 months of symptoms prior to their primary surgical pro-
cedure, showed a lower decrease in NRS pain score than patients with a shorter duration 
of pain (median NRS decrease: 5.5 versus 4.0). The number of operations necessary for 
sufficient pain relief was significantly higher in the group with a longer duration of pain 
(median number of operations: 2 versus 1, Mann–Whitney U test p=0.02).
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Patient characteristics and primary outcomes were not significantly different 
between the groups with and without available nerve block outcomes. The median 
NRS pain score decrease was lower in patients with a poor diagnostic nerve block 
effect (table 7, p=0.11), and zero patients were satisfied with treatment results in this 
group. When considered continuous data, the difference was highly significant (t-test, 
p=0.005).
Discussion
This study was conducted to evaluate patient satisfaction following different surgical 
treatment methods for SBRN neuralgia caused by lesions or adhesions of directly 
traumatized superficial branches of the radial nerve (SBRN), including neurolysis, 
nerve reconstruction, denervation and adjacent nerve neurectomies. Different reloca-
tions of the SBRN end were compared and the prognostic value of a pre-operative 
diagnostic nerve block and patient specific determinants was explored
There have been previous studies evaluating the surgical treatment of SBRN 
neuralgia. However most of these studies comprised small patient numbers.5,6,26,27 or 
did not compare surgical techniques.18,16 None of these studies showed any statistical 
evidence for the superiority of one surgical technique for the SBRN over another. 
This study was performed in a relatively homogeneous population, since all 
patients were involved in neuropathic pain caused by the SBRN, in the dorsoradial 
hand or wrist. There are some limitations to this study that should be discussed. 
The study design was a retrospective cohort study, which might induce the risk of 
information bias. We determined primary and secondary outcomes prior to our study, 
and since follow up data were available for all patients, information bias for patient 
satisfaction was limited. Unfortunately, pre- and post-operative NRS pain scores, as 
well as pain scores following diagnostic nerve blockade, were not available for all 
patients. Patient characteristics and primary outcomes were evenly distributed among 
patients with and without missing data. 
Our study population existed of patients referred to a university medical center 
table 7. Predictive value of diagnostic block
Block effect N Median post-operative NRS pain score (range) % satisfaction
Good 24 4.3 (0.0 - 10) 46%
Poor 4 7.3 (6.0 - 8.0) 0%
Block effect: Good > 3.5; Poor < 3.5 points decrease in NRS pain score; 
Mann-Whitney U test for difference in post-operative pain score: p<0.25
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for expertise in the field of neuropathic pain treatment, and there were a considerable 
number of patients with substantial treatment delays before referral to the study loca-
tion. This might be reflected in the severe and therapy resistant nature of our patients’ 
complaints and therefore negatively influence outcome compared to other medical 
centers and neuropathic pain disorders.
Most patients underwent multiple surgical procedures in the same extremity. It 
is statistically incorrect to analyze all procedures as independent measurements, since 
this leads to an underestimation of variability and inflates sample size.28 This is why 
we separately calculated satisfaction rates for all types of surgical procedures, analyz-
ing only one procedure per patient. 
For neuropathic pain caused by perineural adhesions, external neurolysis provides 
a good primary surgical treatment option, not causing any area of skin anesthesia. 
Satisfaction rates of this procedure vary among literature.5,6 In our study popula-
tion, 12 out of 32 patients treated by external neurolysis were satisfied with surgical 
results. 
The apparent susceptibility of the SBRN to form painful neuromas has been well 
documented,7 and achieving satisfactory pain relief is difficult.16 Treatment failure 
can be caused by incorrect relocation of the SBRN into an insufficiently protective 
environment from mechanical trauma, or into a muscle with large excursion, inducing 
repetitive tension on the nerve. We found that none of the patients with relocation 
of the nerve into the small muscles of the forearm, the interosseous space or silicone 
sheaths were satisfied. Nerve reconstruction was ineffective in relieving pain as well. 
Relocation of the nerve end into the distal radius was effective in two out of six 
patients, and might provide a reasonable treatment option. 
Relocation of the nerve end into the BR muscle was significantly more success-
ful in achieving satisfactory pain relief than relocation elsewhere. The BR muscle 
has little excursion and, therefore, contraction does not induce substantial traction 
or pressure on the nerve. Furthermore, the relatively large muscle belly protects the 
nerve end from mechanical trauma. Our results are supported by the sparse literature 
available.6,16
Remaining or recurrent pain after surgical treatment can also be explained by 
secondary displacement of the translocated neuroma, failure to identify the presence of 
more than one neuroma in the same patient,8 or injury of neighboring nerve branches. 
Mackinnon and Dellon16 found concomitant injury to the LABCN in 75% of patients 
with persistent dorsoradial wrist pain related to a neuroma of the SBRN. After com-
plete neurectomy of the SBRN, adjacent nerves may start to transmit sensory signals 
from the denervated skin area.29 This process is desirable for normal sensory recov-
ery, but can lead to recurrent or sustained pain in surgically treated SBRN neuroma 
patients. Lluch and Beasley15 reported unsatisfactory results due to an overlapping 
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pattern of the PIN with the SBRN. PIN neurectomy was effective in resolving dyses-
thesia without any functional impairment or complications.8 In our study population, 
relatively high satisfaction rates for LABCN and PIN neurectomies were found. In 
case of persistent pain, alternative denervations were incidentally performed of the 
PBMN, the AIN and the radial digital nerve of the thumb.
There is increasing evidence that hyperalgesia is independent of input from 
injured afferents, suggesting that ectopic activity originating from a neuroma is not 
necessary for development of hyperalgesia.11-13 Stokvis et al.14 were the first to report 
this effect in humans. Patients surgically treated for a painful neuroma in the upper 
extremity showed a significant decrease in spontaneous pain after follow up. However, 
the intense symptoms of cold intolerance, also called thermal hyperalgesia, remained 
unchanged. 
Li et al.13 have proposed that interactions between intact and injured nerve fibers 
undergoing Wallerian degeneration may lead to changes in the intact fibers that play a 
critical role for both initiation and maintenance of mechanical hyperalgesia. However, 
Dorsi et al.11 observed reinnervation of denervated skin following peripheral nerve 
injury using the tibial neuroma transposition (TNT) rat-model and did not find 
Wallerian degeneration in the distal nerve stump, indicating that repopulation of the 
distal nerve stump was not due to invasion by axons arising from the tibial nerve but 
rather to recruitment of axons from adjacent nerves from other nerves regenerated 
through the distal stump of the tibial nerve. These findings provide an explanation for 
the beneficial effect of adjacent nerve neurectomies performed in our study. 
Misdiagnosis, or failure to identify the presence of distal reinnervation and 
central sensitization processes, may be avoided by the use of a local diagnostic nerve 
block to accurately identify and anesthetize the sensory nerves involved.8,16,22 Although 
presented to be an effective diagnostic tool,16,30 its ability to predict surgical outcome 
has, to our knowledge, never been reported before. 
In our study, we found a lower median NRS pain score decrease in the group 
with an ineffective pre-operative nerve block (Mann-Whitney U test, p=0.11). At the 
outpatient clinic, patients were asked to rate their pain as any number between zero 
and ten. When viewed as continuous data, the group with an ineffective nerve block 
showed a highly significantly worse outcome compared to patients with an effective 
block (t-test, p<0.01), indicating that patients with no or little effect of diagnostic 
block, should not undergo surgical neuroma treatment. In these patients, attention 
should rather be focused at desensitization, cortical re-organization techniques, and 
pain management.31,32 Another important conclusion we can draw from our results, 
is that high pain reduction after blockade is no absolute guarantee for good outcome 
after surgery, since still 54% of patients with a successful block were unsatisfied fol-
lowing surgical treatment. The use of a continuous Visual Analogue Scale should be 
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considered in future studies measuring pain relief.
Compared to patients treated without delay, we found a significantly higher 
number of operations required for sufficient pain relief, in patients treated with 
duration of pain of at least 12 months prior to their primary surgical procedure. 
These results might be explained by alterations at the level of the spinal cord and 
the somatosensory cortex in the processing of non-painful stimuli.4,33 These changes 
start to develop within hours after the initial nerve injury, and may persist for years 
or decades.34,35
Adequate surgical treatment of peripheral neuropathic pain is challenging. We 
demonstrated the problems of achieving satisfactory pain relief in a population of 
patients surgically treated for neuropathic pain of the SBRN. However, these results 
can be used as an example for treatment strategies for neuropathic pain caused by 
various peripheral nerves. Treatment strategies should take into account the duration 
of symptoms, the possibility of sensory overlap between neighboring nerves, the effect 
of a diagnostic nerve block, and finally, the choice of an appropriate surgical technique 
with respect to local tissue and mechanical characteristics. 
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deterMinantS of Patient SatiSfaction
Determinants of patient satisfaction after neuropathic pain treatment. Stokvis A, Van der 
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Abstract
To accurately study treatment methods for neuropathic pain, the use of appropriate 
outcome measures is essential. Core outcome domains for chronic pain research have 
been proposed in literature. The purpose of this study was to find the determinants 
that are most important for patient satisfaction after surgical treatment for neuro-
pathic pain, caused by peripheral nerve injury. 
Thirty-four patients surgically treated for upper extremity neuroma pain were 
prospectively followed. They returned validated questionnaires on the core outcome 
domains of chronic pain pre- and postoperatively, including the Visual Analogue Scale 
(VAS), McGill Pain Questionnaire (MPQ), Disability of the Arm, Shoulder and Hand 
(DASH), Short Form-36 (SF-36), Symptom CheckList-90 (SCL-90), Tampa Scale 
of Kinesiophobia (TSK) and the Cold Intolerance Severity Scale (CISS). Cut-off 
values for meaningful change were calculated using the reliable change index (RCI) 
and the clinical significant change (CSC) cut-off value. We compared satisfied and 
unsatisfied patient groups for all outcome domains. 
The most important outcome domains were found to be ‘pain’, ‘physical func-
tioning’ and ‘other symptoms’; ‘Emotional functioning’ was not related to satisfactory 
outcome. The VAS for pain was most important for patient satisfaction, and a decrease 
of at least 30 mm or a score below 20 mm on the VAS were found to represent relevant 
changes in pain. The amount of pain indicated as bearable by patients, did not change 
after treatment. The VAS is easy-to-use in clinical practice, readily interpretable and 
should be considered as a primary outcome measure for future studies of neuropathic 
pain treatment.
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Introduction
The importance of chronic pain in our society has become increasingly acknowledged 
over the last decade.1 Peripheral neuropathic pain is a particularly distressing and often 
underestimated chronic pain problem, due to its intensity and little improvement over 
time.2 Although etiologic theories have developed in recent years, truly effective treat-
ment strategies are lacking, and patient satisfaction remains unacceptably low.3
Patients that have developed a painful neuroma in the upper extremity fol-
lowing peripheral nerve injury are an example of a chronic neuropathic pain group 
that suffers from severe physical, emotional, and social problems. Their pain is often 
accompanied by hyperalgesia, allodynia and cold intolerance.4,5 These are often rela-
tively young, otherwise healthy patients that can become severely disabled due to their 
pain problem, resulting in great loss in functionality and high unemployment rates 
with important economical consequences.6-8  Hand function is considered one of the 
most important bodily functions,9 it is vital for performing various work activities. 
Furthermore, painful neuromas in the hand are less protected from mechanical trauma 
compared to other locations, further deteriorating disability. Painful neuromas can be 
treated surgically, but unfortunately, many patients are not satisfied with treatment, 
and the cause of their remaining complaints is often unknown. 
To accurately study treatment methods for neuropathic pain, the use of appro-
priate outcome measures is essential.3 Most studies performed in the area of chronic 
pain focus on only one aspect of treatment outcome.10 They overlook the broad scale 
of physical, emotional, and social problems that can occur in chronic neuropathic pain 
patients.2 However, there is a growing demand to investigate the relationship between 
patient satisfaction and relevant clinical outcomes.11,12 The Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials (IMMPACT) proposed 6 core 
outcome domains that should be considered in chronic pain research,13 and should be 
assessed using validated questionnaires with known psychometric aspects.
Global patient satisfaction ratings with treatment results can be used to inves-
tigate the clinical importance of changes in these outcome domains (Dworkin et al., 
2005).14 The development of patient-centred success criteria involves two main steps. 
Researchers must first indentify which outcome domains are most important to the 
particular patient population, and then establish how much change is required to 
achieve an acceptable outcome.11,15 Since patients may ‘recalibrate’ their criteria for 
success after exposure to treatment, this should be assessed as well.11
This study was performed to find out which factors are most important for patient 
satisfaction after surgical treatment for peripheral neuropathic pain. Understanding 
the relationship between these outcome domains and patient satisfaction may result 
in more effective evaluation of therapeutic methods.
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Methods
Study design
Between January 2006 and August 2009 we conducted a prospective cohort study 
in a University Medical Centre located in the Netherlands. Participants were sent 
validated questionnaires on the core outcome domains of chronic pain prior to surgery 
and after follow up.
Patients
Inclusion criteria were: surgical treatment for neuropathic pain of the upper extremity, 
caused by an injury-related neuroma.  A painful neuroma can be formed after damage 
to peripheral nerve, with subsequent sprouting of axons into surrounding scar tissue.16 
Patients with a different cause of neuropathic pain, i.e. nerve adhesions or entrap-
ments, were excluded, as well as patients who did not undergo surgery and patients 
who were unable to accurately fill out and return both questionnaires.
Surgical treatment consisted of excision of the neuroma, if possible followed by 
nerve repair using nerve grafts or neurotubes when necessary. If the distal nerve end 
was not available for repair, the proximal nerve stump was relocated away from the 
site of injury and buried into muscle or bone.5
Scoring methods
The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials 
(IMMPACT) recommended 6 core outcome domains that should be considered in 
chronic pain research.13 These 6 core outcome domains are (I) pain; (II) physical 
functioning; (III) emotional functioning; (IV) participant ratings of improvement 
and satisfaction with treatment; (V) other symptoms and adverse events during treat-
ment; and (VI) patients disposition and characteristics data. These core domains were 
assessed using questionnaires and specific questions discussed below (table 1). All 
questionnaires are commonly used in pain research and were previously validated.
Patient Satisfaction
Patients were requested to rate their satisfaction as satisfied or unsatisfied. This data 
was used to investigate participants’ judgments of the clinical importance of changes 
in other outcome measures, by comparing improvement in core outcome domains 
between satisfied and unsatisfied patients.
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Visual Analogue Scale
The visual analogue scale (VAS) for pain consists of an unmarked horizontal line of 
100 mm, anchored with the words ‘no pain at all’ on the left side and ‘unbearable pain’ 
on the right. The patient has to place an x on the line representing the amount of pain 
felt. The VAS score ranges from 0 to 100. Although the VAS score represents data that 
lay between ordinal and interval (continuous) values, it is most appropriately analyzed 
using parametric techniques.17 We applied a quadruple VAS, regarding current pain 
intensity (at this moment), pain intensity during the past week, minimal/maximal and 
bearable pain. These measures were used to compare patients’ pain experience and cut 
off scores for bearable pain before and after treatment.15 Current VAS pain intensity 
data was used for satisfaction analyses.
Disabilities of the Arm, Shoulder and Hand 
The disabilities of the arm, shoulder and hand (DASH) questionnaire is a measure of 
self-rated upper extremity disability and symptoms. It is the most widely used upper 
extremity-specific health-status measure.18 The DASH consists of a 30-item disability 
scale, scored 0 (no disability) to 100 (most severe disability). In addition, two optional 
modules on work and sport activities can be filled out, leading to separate scores. The 
Dutch version of the DASH has been validated by Veehof et al.19.
McGill Pain Questionnaire
The McGill Pain Questionnaire (MPQ) was developed by Melzack et al.20 and has 
table 1: Core outcome domains, defined by The Initiative on Methods, Measurement, and 
Pain Assessment in Clinical Trials (IMMPACT)
IMMPACT Outcome Domain Question(naire)s
(I) Pain Visual Analogue Scale
McGill Pain Questionnaire
(II) Physical functioning Disability of the Arm, Shoulder and Hand
Short Form-36 Physical score
(III) Emotional functioning Short Form-36 Mental score
Symptom CheckList-90
(IV) Improvement and satisfaction with 
treatment
Patient satisfaction
(V) Other symptoms or adverse events Tampa Scale of Kinesiophobia
Cold Intolerance Severity Scale
Treatment complications
(VI) Patient characteristics and disposition Sex, age, duration of pain, dominant side 
affected, socio-economic status
86
Chapter 6
been described as the leading instrument to describe the diverse dimensions of pain.21 
The MPQ-Dutch language version (MPQ-DLV) was composed and validated by 
Van der Kloot et al.22. It consists of 78 pain descriptors classified into 20 categories 
of pain that can be scored to assess 3 major psychological dimensions of pain: sensory 
(PRI-s), affective (PRI-a) and evaluative (PRI-e) pain, as well as a total pain severity 
score (PRI-T) and the total number of words selected within each pain dimension 
(NWC). 
Short Form-36
The short form-36 (SF-36) health survey developed by Ware and Sherbourne23 is the 
most commonly used measure of health related quality of life.14 It consists of 36 items 
that assess 8 health dimensions: limitations in physical activities because of health 
problems; limitations in social activities because of physical or emotional problems; 
limitations in usual role activities because of physical health problems; bodily pain; 
general mental health; limitations in usual role activities because of emotional prob-
lems; vitality and general health perceptions. The scores range between 0 (worst) and 
100 (best) for each dimension. Two summary scores can be calculated from these 
dimensions: the physical and mental health components (PCS and MCS). Translation 
and validation of the Dutch language version of the SF-36 has been performed by 
Aaronson et al.24. They provided normative data to standardize each scale to the mean 
and standard deviation of the general Dutch population.
Symptom Checklist-90 
The symptom checklist-90 (SCL-90) is used to measure self-reported symptoms of 
psychopathology.25 It consists of 90 symptoms that are scored from 1 (never) to 5 (very 
often). The Dutch version of the Symptom Checklist-90 was validated by Arrindell 
and Ettema26, and includes scores eight subscales, namely  “Anxiety”, “Agoraphobia”, 
“Depression”, “Somatic complaints”, “Suspicion and interpersonal sensitivity”, 
“Insufficient thinking and behaviour”, “Sleeping problems” and “Anger-hostility”. 
The SCL-90 total score for “psychoneuroticism” ranges between 90 and 450. 
Tampa Scale of Kinesiophobia
The Tampa Scale of Kinesiophobia (TSK) assesses the participants’ fear of (re)injury 
by physical movement or activity. 17 items are rated on a 4-point scale from “strongly 
disagree” to “strongly agree”, higher scores indicating stronger fear of (re)injury. The 
TSK has shown to be a reliable assessment tool for chronic pain and recent studies 
have supported a two-factor solution with subscales for activity avoidance (AA) 
and somatic focus (SF).27 A shortened version of the TSK, the 13 items without 
the reversed key items, was shown to be preferred over the original 17-item TSK by 
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Goubert et al.28. In our analysis, we used the 13 item TSK, providing a total score, as 
well as the AA and SF subscales.
Cold Intolerance Severity Score 
The severity of posttraumatic cold intolerance was measured using the self-admin-
istered Blond McIndoe cold intolerance severity score (CISS) questionnaire, which 
has been validated in both a peripheral nerve injury group and a normative control 
group.29,30 The CISS questionnaire consists of 6 questions relating to the frequency, 
duration, severity, and impact of cold intolerance symptoms on activities of daily life. 
The CISS questionnaire has a minimum score of 4 and a maximum score of 100.
Complications
Medical records were reviewed for any treatment reported complications, including 
post-operative pain, wound infection and haemorrhage.
Patient characteristics and disposition 
The pre-operative questionnaire contained questions concerning patient specific 
factors such as age, gender, length, weight, dominant arm affected, education and 
income. Duration of pain was defined as time between the development of neuroma 
pain and surgery. Patients’ socio-economic status was categorized into 3 groups, 
according to level of education and income.
Statistical methods
Patients were analyzed in two groups: satisfied and unsatisfied. Mean pain domain 
scores and pre- to post-operative change was compared between these groups. For all 
variables, a Kolmogorov-Smirnov (K-S) goodness-of-fit test for normal distribution 
was performed. 
For all measures, cut-off values for meaningful change were determined using 
the reliable change index (RCI) and the clinical significant change (CSC) cut-off 
value, as described by Jacobson et al.31. The RCI is used to determine the minimal 
change necessary to identify true change between two measurements in a patient, 
which is not due to chance or the unreliability of the measurement. RCI values follow 
the normal distribution and a value of >1.96 is considered a reliable change. The RCI 
can be calculated using the reliability of a test (Cronbach’s alpha or the test-retest 
reliability coefficient) and the standard deviation (SD) of the measure obtained from 
the clinical population.25 
Aside from statistical reliable change, clinically significant change is important 
for clinical practice. The CSC provides a cut-off value for clinically meaningful 
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change. This cut-off point can be calculated using three different criteria proposed by 
Jacobson et al.31 depending on the availability of normative data for the measure under 
study. Criterion (a) only requires the data obtained from the clinical population. CSC 
is defined as a value that falls outside the 2 SD range of the clinical population, in this 
case the pre-operative score. Criterion (b) defines CSC as a post-operative value that 
falls inside the 2 SD range of the normative population. Criterion (c) uses both the 
clinical and the normative data to establish a cut point that lies between the means 
of these populations. CSC is reached when the statistical probability of falling in the 
normative population is higher than falling in the clinical population. When norma-
tive data is available, and the two distributions overlap, criterion (c) is preferred over 
(b).31 Reliability and normative data for all measures were obtained from published 
reports. 
We combined the RCI-values and CSC cut points to identify patients who 
underwent a statistically reliable and clinically meaningful change in outcome measure. 
For all measures, the proportion of patients with a reliable and/or clinical significant 
change was calculated and compared among satisfaction groups using Fisher’s exact 
test.
To assess whether patients recalibrate their criteria for success after exposure to 
treatment, we compared the bearable VAS scores as indicated by patients before and 
after treatment.
Furthermore, we compared the mean scores for continuous measures between 
satisfied and unsatisfied patients, using an independent t-test. All tests were two sided 
and a p-value of less than 0.05 was considered statistically significant. To correct for 
multiplicity of endpoints, the Bonferroni correction was also provided, defining a 
statistically significant difference as a p-value of less than α/K, where K is the number 
of endpoints tested.  For this study the Bonferroni correction was 0.05 (α) divided by 
16 secondary endpoints, resulting in a significant p-value of <0.0031, or <0.05 with 
p+0.0469. All data analyses were performed using Statistical Package for the Social 
Sciences (SPSS, Chicago, Illinois, USA), version 16.0. 
Results
45 patients were sent a questionnaire pre-operatively. Two patients did not want to 
cooperate. In 7 cases, no neuroma was found during surgery and only external neu-
rolysis was performed. These patients were excluded from our study. One patient 
did not undergo surgery after all. Averagely 23 months (range 3 to 37) after surgical 
treatment, final follow up questionnaires were sent to 35 patients. The 34 patients 
surgically treated for a painful neuroma of the upper extremity who returned the 
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follow up questionnaire were included in our analyses. Patient characteristics are pre-
sented in table 2. The study population consisted of 18 males and 16 females, with an 
average age of 43. The average duration of pain was 44 months. In 25 out of 34 cases, 
the dominant hand was affected. 
For all measures, the K-S test p-values were above 0.05, indicating a normal 
distribution for all measures. Cronbach’s alpha could be obtained from literature for 
all measures accept the VAS and CISS scores. For these measures, a test-retest reli-
ability coefficient was used to calculate the value that equals RCI>1.96, the RCI-value. 
Normative data was available for the SF-36, SCL-90, DASH and CISS scores. For 
these measures, the CSC cut-off point could be calculated using Jacobson’s criterion 
(c). For the MPQ, Tampa and VAS scores, no normative data was available and crite-
rion (a) was used. The CSC cut-off points for all subscales of the MPQ were below 
zero, therefore these could not be used.  All clinical and normative population means, 
reliability measures, RCI-values, CSC cut off scores and Jacobson’s criteria used, are 
displayed in table 3.
The mean scores for most outcome domains differed significantly between 
the satisfied and unsatisfied patient groups (table 4). The outcome measures that 
were most significantly different between satisfaction groups were the VAS for pain, 
the MPQ PRI-e and the CISS (p<0.001). The measures for the outcome domain 
‘pain’ were highly significantly correlated with each other (VAS and PRI-e, r=0.76, 
p<0.001). Other measures that were significantly different between the satisfied and 
unsatisfied patient groups were the DASH and PRI-T scores (p=0.001), followed by 
the SF-36 PCS (p=0.002), the MPQ PRI-s (p=0.005) and NWC (p=0.004) subscales, 
the DASH work score (p=0.005) and the TSK (p=0.006), including its AA (p=0.017) 
and SF (p=0.01) subscales. Most of the 8 health dimensions of the SF-36 were sig-
table 2. Baseline characteristics (N=34)
Characteristic
Age in years,: mean (SD) 42.8 (13.7)
Sex: male - female 18  - 16
Dominant arm affected 25
Duration of pain in months, mean (SD) 44.0 (40.1)
Social economic class:
1 high
2 middle
3 low
12
18
4
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table 3. Reliable and clinical significant change data
Clinical 
population 
pre-operative 
score (SD)
Normative 
population 
score (SD)
Reliability 
coefficient
RCI-value CSC cut 
point
Jacobson’s 
criterion
VAS 66.2 (23.2) NA 0.80 28.7 <19.8 a
MPQ DLV
PRI-s
PRI-a
PRI-e 
PRIT
NWC
12.1 (7.1)
3.2 (3.4)
6.7 (2.8) 
21.9 (12.0)
11.3 (5.4)
NA 0.61
0.66
0.65 
0.80
0.82
12.3
5.5
4.6
14.9
6.4
Cut-off 
scores 
below zero
a
DASH
Sport 
Work
48.7 (21.3)
74.3 (32.2)
52.2 (30.7)
10.1 (14.7)
9.8 (22.7)
8.8 (18.4)
0.96 11.8
17.9
17.0
<25.9
<36.5
<25.1
c
SF-36
PCS 
MCS
38.9 (6.6)
60.0 (6.4)
50 (10) 
50 (10)
0.84
0.84
7.3
7.1
>43.3
>56.1
c
SCL-90
PSNEUR 121.9 (33.1) 118.3 (32.4) 0.97 15.9 <120.1
c
TSK
AA
SF
30.2 (7.8)
19.1 (5.8)
11.1 (3.2)
NA 0.80
0.73
0.70 
9.7
8.4
4.9
 <14.6
<7.5
<4.7
a
CISS 53.0 (19.3) 12.9 (8.2) 0.90 16.9 <24.8 c
Reliability coeff icients and normative population scores taken from literature. Crohnbach’s alpha was 
used for all questionnaires except the VAS and CISS scores. For the VAS and CISS scores the test-retest 
correlation coeff icient was used.
RCI-value: Reliable Change Index value: change in pre- post-treatment score that equals RCI>1.96; 
CSC: Clinical Signif icant Change; Jacobson’s criterion a: CSC outside the 2 SD range of the clinical 
population, b: CSC within 2 SD range of the normative population, c: CSC with higher statistical 
probability of falling into the normative population than the clinical population.
VAS: Visual Analogue Scale (pain, range 0-10)35; MPQ: McGill Pain Questionnaire (psychological 
dimensions of pain)22, PRIT: Pain rating Intensity Total (range 0-63), NWC: Number of Words 
Chosen (range 0-20), PRI-s: Pain Rating Intensity sensory (range 0-36), PRI-a: Pain rating 
Intensity affective (range 0-15), PRI-e: Pain rating Intensity evaluative (range 0-12); DASH: 
Disability of the Arm, Shoulder and Hand (range 0-100)19; SF-36: Short Form 36 (quality of life)24, 
PCS: Physical Component Summary score (range 0-100), MCS: Mental Component Summary 
score (range 0-100); SCL-90: Symptom Checklist 90 (symptoms of psychopathology)26, PSNEUR: 
Psychoneuroticism score (range 90-450); TSK: Tampa Scale of Kinesiophobia (fear of re-injury)28, 
AA: Activity Avoidance (range 8-32), SF: somatic focus (range 5-20); CISS: Cold Intolerance 
Severity Scale (range 4-100)29,30.
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t
able 4. O
utcomes compared among satisfaction groups
 
Post-operative score (SD)
No. of patients with CSC / total
No. of patients with RC / total
No. of patients with RC &
 CSC 
/ total
Satisfied
Unsatisfied
Satisfied
Unsatisfied
Satisfied
Unsatisfied
Satisfied
Unsatisfied
VAS
27.4  (23.7)
71.4 (23.6) c
9/19
1/15
a
10/19
1/15
b
7/19
0/15
a
M
PQ DLV
PRI-s
PRI-a
PRI-e
PRIT
NW
C
7.0 (5.8)
1.6 (2.5)
3.6 (2.8)
12.2 (10.4)
7.6 (5.1)
13.7 (7.0) b
4.0 (4.5)
7.9 (1.7) c
25.6 (11.5) c
13.1 (4.8) b
NA
NA
2/18
2/18
8/18
7/18
6/18
0/14
0/14
0/14
b
0/14
a
1/14
NA
NA
DASHSport
work
29.7 (19.7)
37.5 (33.4)
57.6 (31.4)
55.8 (21.1) c
85.4 (13.0)
24.6 (21.3) b
8/19
3/5
7/16
2/15
0/33/9
12/19
2/4
11/13
2/13
a
0/2
2/7
a
6/19
6/90/8
0/13
2/40/5
SF-36PCS
M
CS
44.4 (6.9)
57.4 (6.2)
36.2 (7.2) c
59.7 (8.4)
9/19
13/19
2/15 
11/15
7/19
1/19
0/15
a
1/15
6/19
1/19
0/15
a
1/15
SCL-90 
PSNEUR
127.0 (48.4)
135.5 (48.3)
11/19
5/14
4/17
1/13
3/17
0/13
TSKAASF
23.2 (6.9)
14.7 (4.3)
8.5 (3.1)
31.5 (9.6) b
20.0 (6.9) a
11.5 (3.3) a
2/19
0/19
0/19
0/15
0/15
0/15
6/18
5/18
5/18
0/15
a
0/15
a
1/15
1/18
0/18
0/18
0/15
0/15
0/15
CISS 
36.7 (23.4)
70.5 (26.9) c
6/19
1/15
9/19
0/13
b
5/19
0/13
CSC: clinical significant change; RC: reliable change; a Significant difference between satisfied and unsatisfied group with p<0.05; b Significant 
difference p<0.01;  c Significant difference p<0.0031 (p<0.05 with Bonferroni correction of +0.0469).
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nificantly different, the greatest difference was found in the ‘bodily pain’ dimension 
(p<0.001). Dimensions that were no different between both satisfaction groups were 
‘mental health’, ‘vitality’ and ‘general health perception’. For the SCL-90 and all its 
subscales no significant differences could be found. Other outcome measures that 
were not significantly different were the SF-36 MCS, the DASH sport score and the 
MPQ PRI-a.
We calculated the proportion of patients with a reliable and/or clinically meaning-
ful change in score after surgical treatment, and compared these proportions between 
the satisfied and unsatisfied patient group (table 4). The proportion of patients that 
reached a RCI of >1.96 was also different between both groups for most measures 
under study. The proportion of patients with a reliable change in MPQ PRI-e score 
was 8 out of 18 in the satisfied group, compared to 0 out of 14 patients in the unsatis-
fied group (p=0.004). Other significant differences between the satisfaction groups 
were found for the VAS score for pain (p=0.008), the SF-36 PCS (p=0.011), the total 
DASH (p=0.012) and DASH work score (p=0.022), the MPQ PRI-T (p=0.01), the 
total Tampa (p=0.021) and AA subscale (p=0.049), and the CISS score (p=0.004).
Patients with a clinically meaningful change were less common. This is repre-
sented in the small differences between the satisfied and unsatisfied patient groups. 
The only significant difference in number of clinically changed patients was found for 
the VAS score for pain: 9 out of 19 patients reached the CSC-cut point in the satisfied 
group, compared to 1 out of 15 patients in the unsatisfied group (p=0.02). When we 
compared the proportion of patients with a reliable and clinical significant change 
among satisfaction groups, we again found that only the VAS score for pain differed 
significantly (7/19 vs. 0/15, p=0.011).
Bearable pain, as indicated by patients on a VAS pre-operatively, did not change 
after surgery. The mean bearable VAS score was 40 (SD 28) before and 41 (SD 25) 
after surgery. Patients self-reported current VAS score was lower or equal to the self-
reported bearable VAS score in 14 out of 19 satisfied patients, compared to 3 out of 
15 unsatisfied patients (p=0.005).
For only one patient a complication was reported, this patient developed complex 
regional pain syndrome after surgical treatment. 
Finally, we analyzed the differences in patient characteristics between satisfac-
tion groups (table 5). The duration of pain in the unsatisfied group was approximately 
twice as long compared to the satisfied group (60.5 vs. 30.9 months, p=0.05). Age, sex, 
duration of pain, dominant arm affected and social-economic status were not related 
to a satisfactory outcome.
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Discussion and conclusions
This study was performed to determine which factors are most important for patient 
satisfaction following surgical treatment for upper extremity neuropathic pain. We 
compared post-operative scores between satisfied and unsatisfied patient groups for 
all important outcome domains for chronic pain. Furthermore, we compared the pro-
portions of patients reliably and clinically significantly changed among these groups, 
using the method described by Jacobson et al.31. Absolute scores, as well as the propor-
tion of patients with a statistically reliable improvement  were significantly different 
between satisfied and unsatisfied patients in the core outcome domains ‘pain’, ‘physical 
functioning’ and ‘other symptoms’, but not in ‘emotional functioning’. The propor-
tion of patients with clinically significant improvement was significantly higher in 
the satisfied group only for VAS-score for pain; the other measures did not differ 
significantly. The amount of pain classified as bearable by patients, did not change 
after treatment.
Patient satisfaction can be influenced by many factors of which we measured the 
most important according to the IMMPACT recommendations.13 However, there are 
some limitations to this study that we will now discuss. Hirsh et al.12 showed a sig-
nificant influence of patients’ expectations and their satisfaction with care on overall 
patient satisfaction, however, these issues were not assessed in this study. Furthermore, 
we did not use a specific neuropathic pain measurement tool, like the Neuropathic 
Pain Questionnaire,32 neither were patients’ coping strategies assessed.
In contrast to the number of measures with a statistically reliable change, only 
one measure reached a clinically significant change following treatment: the VAS 
score. This could reflect an actual phenomenon or could indicate the use of criteria 
that are too stringent to calculate a CSC cut-off score.
The likelihood of obtaining statistically significant results by chance increases 
table 5. Patient characteristics and satisfaction
Characteristic Satisfied Unsatisfied p-value
Age: mean (SD) 42.8 (12.0) 42.8 (16.0) 0.99
Sex: male - female 11/18 - 8/16 7/18 - 8/16 0.73
Dominant arm affected 15/19 10/15 0.46
Duration of pain in months: mean (SD) 30.9 (22.7) 60.5 (51.1) 0.05
Social economic class:
1 high
2 middle
3 low
8
9
2
4
9
2 0.65
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with the number of analyses performed, however, the problem of multiplicity is reduced 
when the outcome measures are positively correlated.33 We provided the Bonferroni 
correction to correct for multiplicity of secondary endpoints. The difference between 
satisfied and unsatisfied patient groups in achieving a reliable and clinically significant 
change did not reach significance following the Bonferroni correction of p+0.0469 for 
any measure.
There are some important strengths to this study. It was performed with a prospec-
tive follow-up design, thereby minimizing the risk of information bias. The response 
rate was very high, reducing possible selection bias. Patients with an injury-related 
neuroma of the upper extremity provide a homogeneous study population. This is pre-
ferred to studies that combine patient groups with differences in aetiology, symptoms 
and treatment,2,10,34 which might result in biased conclusions.3 Another advantage of 
this study population is that these are relatively young and otherwise healthy patients. 
Other studies focusing on chronic neuropathic pain often involve diabetes; this afflic-
tion often occurs at a higher age and is associated with much co-morbidity, which can 
obscure primary outcomes. Another often studied neuropathic pain disorder is post-
herpetic neuropathy. Compared to this patient group, our study population is likely 
to be more severely affected by disability, because of the intense pain located in the 
upper extremity. To date, the treatment of diabetic and post-herpetic neuropathic pain 
focuses mainly on symptom alleviation, since curative treatments are not yet available. 
Furthermore, those treatment schemes are subject to non compliance. In our patient 
population, surgical treatment was performed in all patients, with a curative intention. 
All patients underwent approximately the same surgical procedure, so results were less 
affected by differences in treatment. 
There has been increasing demand to investigate the relationship between 
patient satisfaction and symptom relief.12 We provided new insights in the experi-
ence of chronic pain by determining the factors most important for satisfaction, in 
peripheral neuropathic pain patients. Only previously validated questionnaires, with 
sufficiently high reliability coefficients were used.
In a study defining success criteria for the treatment of chronic spine pain 
by Brown et al.11, patients adjusted their criteria for success over time by becom-
ing less stringent. In our study population, bearable pain reported by patients was 
similar before and after treatment (40/100 vs. 41/100). The different results might be 
explained by the fact that in the study by Brown et al. there was 21% loss to follow up, 
and those patients had significantly more stringent success criteria before treatment 
(p<0.05). Furthermore, the test-retest reliability of the Patient-Centred Outcomes 
Questionnaire they used to determine success criteria, was questionable (r=0.43-0.58). 
We used the VAS for pain with good test-retest reliability (r=0.80)35 and there was 
only one patient lost to follow up, who was excluded from analysis.
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The outcome domain ‘pain intensity’ was found to be most important for a sat-
isfactory outcome. This is not surprising, since these were patients treated for chronic 
neuropathic pain. The VAS score and PRI-e were the measures most significantly 
important for patient satisfaction. 
Clear and easy-to-use cut-off values were found for the VAS score for pain. When 
rounded off, a decrease of at least 30 mm or a score below 20 mm on the 100 mm scale 
were found to represent relevant changes in pain. These cut-off values are similar to 
values found in previous literature concerning the VAS. Although the MPQ-DLV is 
somewhat more time consuming to administer, the MPQ PRI-e subscale regarding 
the overall intensity of the pain experience is composed of only 3 questions.22
Since both measures were significantly correlated with each other (p<0.001), it 
would be sufficient to use only one of both when assessing the outcome after periph-
eral neuropathic pain treatment. For everyday clinical practice, it is important to use 
outcome measures that are easy to use and are reliable.36 The VAS meets both these 
criteria, and no other pain scale consistently demonstrates greater responsiveness in 
detecting improvements associated with pain treatment.14
From our results it seems that ‘emotional functioning’ does not play an important 
role in patients’ self-reported satisfaction. The mean quality of life mental component 
score (SF-36 MCS) was high compared to the normative population, indicating a 
good mental health. Schmitz and Kruse37 demonstrated that a co-morbid somatic 
condition may affect the performance of the scores; physical impairment may increase 
the SF-36 MCS because of a negative weighting, possibly explain the relatively high 
mean MCS score in our population. Self-reported symptoms of psychopathology, 
measured with the SCL-90 were also below average, indicating a good mental health. 
All subscales were similar among satisfaction groups. These findings are in contrast 
with the available pain literature stating that chronic pain is often accompanied by 
symptoms of psychological distress and psychiatric disorders, including depression, 
anxiety, anger and sleep disturbances.3,14 This difference could results the actual mental 
state of peripheral neuropathic pain patients, however, it might also be due to patients 
in our study population emphasizing the physical aspects of their pain problem, and 
underreporting their emotional stress.
The other outcome domains, ‘physical functioning’ (DASH, SF-36 PCS), ‘other 
symptoms and adverse events during treatment’ (TSK, CISS) and ‘patients disposition 
and characteristics’ (duration of pain) were important for patient satisfaction, but to a 
lesser extent than ‘pain intensity’. Therefore, the necessity to evaluate these domains 
in all patients treated for neuropathic pain is questionable.
In conclusion: In patients treated for chronic neuropathic pain of the upper 
extremity caused by peripheral nerve injury, the most important outcome domains 
were found to be ‘pain’, ‘physical functioning’ and ‘other symptoms’. Emotional func-
96
Chapter 6
tioning was not related to satisfactory outcome. The most important measure for 
patient satisfaction was the VAS score for pain. This measure is easy-to-use in clinical 
practice, readily interpretable and should be considered as a primary outcome measure 
for future studies of neuropathic pain treatment.
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Chapter 7:
Surgical treatMent of neuroMa Pain
Surgical management of neuroma pain: a prospective follow-up study. Stokvis A, Van der 
Avoort DJJC, Van Nek JW, Hovius SER, Coert JH. Under revision for Pain.
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Abstract
Painful neuromas can cause severe loss of function and have great impact on the 
daily life of patients. Surgical management remains challenging; despite improving 
techniques, success rates are low. To accurately study the success of surgical neuroma 
treatment and factors predictive of outcome, a prospective follow-up study was 
performed.  
Between 2006 and 2009, pre- and post-operative questionnaires regarding pain 
(VAS, McGill), function (DASH), quality of life (SF-36), symptoms of psychopathol-
ogy (SCL-90), epidemiologic determinants and other outcome factors were sent to 
patients surgically treated for upper extremity neuroma pain. Pain scores after diag-
nostic nerve blocks were documented at the outpatient clinic before surgery. 
34 patients were included, with an average follow up time of 25 months. The 
mean VAS score decreased from 6.8 to 4.9 after surgery (p<0.01), 19 (56%) of patients 
were satisfied with surgical results. Upper extremity function improved significantly 
(p=0.001). Neuroma patients had a significantly lower quality of life compared to 
a normal population. Employment status was predictive of the outcome (p<0.05). 
VAS scores after diagnostic nerve block were predictive of post-operative VAS scores 
(p=0.05). Furthermore, smoking was significantly related to worse outcome (RR 2.06, 
p<0.05).
These results could lead to improved patient selection and treatment strategies. 
If a diagnostic nerve block is ineffective in relieving pain, patients will most likely not 
benefit from surgical treatment. Patients should be encouraged to focus on activity 
and employment instead of their symptoms. Smoking should be strongly discouraged 
in all patients who will undergo surgical neuroma treatment.
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Introduction
Neuropathic pain caused by symptomatic neuromas is an important problem follow-
ing peripheral nerve injury, seriously affecting patients’ daily life. The incidence of 
symptomatic neuromas is estimated at approximately 3-5% of all patients involved in 
peripheral nerve injury.1 The extreme spontaneous pain, allodynia, hyperalgesia and 
cold intolerance cause loss of function and productivity,2 resulting in high unemploy-
ment and workers compensation rates as well as high health care expenditures.3,4
Neuromas are formed when nerve recovery towards the distal nerve end or 
target organ fails and axons sprout into the surrounding scar tissue. They consist 
of a deranged architecture of tangled axons, Schwann cells, endoneurial cells, and 
perineurial cells in a dense collagenous matrix with surrounding fibroblasts.5 There is 
an up-regulation of sodium channels, adrenergic receptors, and nicotinic cholinergic 
leading to abnormal sensitivity and spontaneous activity of injured axons.6 As ectopic 
peripheral nerve input continues, changes at the spinal cord and sensory cortex level 
start to take place, creating a state of central sensitization.7
Unfortunately, treatment of patients with neuroma pain is difficult. Many treat-
ment methods have been proposed, such as, injections of the nerve stump with various 
chemical agents, transcutaneous electrical nerve stimulation (TENS), topical lido-
caine, repeated nerve blocks, desensitization techniques and adjuvant pain medication 
like antidepressants and anticonvulsants.8 The treatment of disabling neuropathic 
pain following nerve injury is a topic that is of timeless interest to plastic- and neu-
rosurgeons, orthopedic and general Surgeons, as well as anesthesiologists and pain 
management teams, but an entirely effective treatment method has yet to be found.9 
Although not all pain specialist are aware of this option, peripheral nerve surgery can 
provide a permanent effect on pain relief, as opposed to the life-long use of analgesic 
medication or medical devices. 
Best results are usually obtained with reconstruction of the nerve using nerve 
grafts or neurotubes, or relocation of the painful nerve into an environment away 
from the original injury site and protected from mechanical, thermal, or other injury 
of the nerve,10 for example into bone, muscle or vein.11  End-to-side anastomoses or 
nerve loops can also provide satisfactory results.9 Despite the use of these techniques, 
remaining or recurrent pain is a common finding.7 
For decision making processes and patient education, it is important to know the 
effect of surgical treatment on different outcome domains. Since treatment failure is 
common, it can be important to point out patient groups that will not likely benefit 
from surgical treatment. Patient-specific prognostic factors, predicting insufficient 
pain relief after surgical neuroma treatment, can help clinicians in the process of 
patient selection, treatment and care. The current study was performed to evaluate the 
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effect of surgical neuroma pain treatment on multiple important outcome domains 
and to find prognostic factors for insufficient pain relief, including the predictive 
value of commonly used diagnostic nerve blocks.
Methods
Between January 2006 and August 2009, we conducted a prospective follow-up study 
on surgically treated upper extremity neuroma pain patients. Included patients were 
diagnosed with neuroma specific neuropathic pain after presenting with a history 
of nerve injury to the upper extremity, followed by symptoms of a painful neuroma 
including spontaneous pain, electrical spikes or burning pain, allodynia and hype-
ralgesia to touch, pressure or movement.12 Clinical examination typically showed 
a shooting electrical pain when tapping the injured nerve (positive Tinel’s test). In 
most cases, a diagnostic nerve block with 1% lidocaine was performed at the outpa-
tient clinic, to confirm involvement of the suspected nerve in the painful sensation.13 
The effect of this nerve block was registered by the hand surgeon on a 0-10 pain 
scale. Patients that were selected by the hand surgeon to sustain a surgical procedure 
were sent a questionnaire approximately 2 weeks prior to their operation. Follow-up 
questionnaires assessing primary and secondary outcomes were sent to all included 
patients with a follow-up period of at least 3 months.
Patients were operated under general anesthesia combined with a local block or 
under regional anesthesia. Pre-operatively the location of maximum pain was marked. 
After opening the skin, the nerve was neurolyzed from the surrounding scar tissue 
and the neuroma was excised. If a neuroma-in-continuity or a nerve transection with 
an available distal stump was present, continuity was restored. If the distal nerve was 
not available for repair, the proximal stump was buried into bone or muscle, preferably 
proximally to the site of injury. In some cases other techniques were applied such as a 
nerve loop or silicone sheath. Tension on the nerve was always avoided. 
The lateral antebrachial cutaneous nerve (LABCN), posterior interosseous nerve 
(PIN), palmar branch of the median nerve (PBMN) and the anterior interosseous 
nerve (AIN) may have overlapping sensory innervation with SBRN. In case of recur-
rent or persistent pain, the suspected adjacent nerve involved was diagnostically 
blocked with 1% lidocaine and if the block showed a considerable pain reduction, a 
denervation was performed.
Primary outcomes were patient satisfaction (yes or no) and pain scored pre- and 
post-operatively on a 10 cm visual analogue scale (VAS), ranging from 0 ‘no pain at 
all’, to 10 ‘unbearable pain’. Cut off scores for insufficient pain relief were defined as 
less than three points decrease on the VAS pain scale, or a final VAS score above 2, 
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using the reliable change index (RCI) and clinical significant change (CSC) (data not 
shown).14-16 
We evaluated the effect of treatment on important secondary outcome domains, 
including pain, physical and emotional functioning and accompanying symptoms, 
as proposed by the Initiative on Methods, Measurement, and Pain Assessment in 
Clinical Trials (IMMPACT).17 These secondary outcomes were assessed using vali-
dated questionnaires, including the McGill pain questionnaire (MPQ), which divides 
pain into sensory-discriminative, affective-motivational, and evaluative-cognitive 
pain18; the SF-36 for physical and emotional quality of life assessment19; the SCL-90 
for assessment of psychological problems and psychopathology20; the Tampa scale 
for kinesiophobia (TSK)21, which measures the patient’s anxiety for being physically 
active; and the disability of arm, shoulder and hand (DASH) questionnaire, with its 
subscales for work and sport activities.22 Pre- and post-operative scores were compared 
to each other and to normative population scores found in literature. Furthermore, 
we looked at different pain modalities, as described by Sood and Elliot12, and their 
improvement following surgical treatment. These include ratings of spontaneous pain, 
pain on pressure or movement, and hypersensitivity.
Prognostic factors such as employment status, workers compensation and litiga-
tion involvement, number of previous operations and duration of pain,7 as well as 
other patient characteristics such as sex, body mass index (BMI) and smoking status 
and socio-economic status were evaluated for their effect on primary outcome. We 
also compared the effect of all surgical procedures performed during our study and 
compared the outcome for the different nerves involved in the upper extremity. The 
predictive value of the diagnostic nerve block performed at the outpatient clinic was 
determined by comparing pain scores following the nerve block with those following 
surgical treatment. Pain medication usage, type and frequency, were recorded both 
pre-operatively and after follow-up.
Student’s t-tests were used to compare two independent means and for compar-
ing pre- and post-operative data the paired t-test was used. For paired ordinal data 
the Wilcoxon signed rank test was used. Chi square tests were performed for 2 by 2 
contingency tables, when the minimum expected count per cell was at least 5. For 2 by 
2 tables not meeting this criterion, Fisher’s exact test was performed. For prognostic 
factors for the primary outcome, relative risks (RR) with 95% confidence intervals 
(95% CI) were calculated. Stratification was performed in case of possible confounding 
of results. The Mantel-Haenszel adjusted relative risk was used to provide a weighted 
average of the stratum-specific relative risks. To evaluate correlations between ordinal 
and continuous data, the non-parametric Spearman’s rank correlation coefficient was 
used. Pearson’s correlation coefficients were used for continuous data. Although mul-
tiple procedures and measurements were available for some patients, only the final 
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operation of patients was used to compare groups, to avoid an underestimation of 
variability and inflation of sample size. 
This study was approved by the Medical Ethics Committee of our institution 
(MEC-2007-094).
Results
From January 2006 through August 2009, pre-operative questionnaires were sent 
to 45 patients. Two patients did not return the questionnaire. Seven patients were 
excluded as no neuroma was found during surgery and only external neurolysis was 
performed. One patient decided to refrain from further surgical treatment. The follow 
up questionnaire was sent to 35 patients and returned by 34 patients, 1 patient did not 
respond. Demographics of the 34 included neuroma patients are presented in table 1. 
table 1. Baseline characteristics
Characteristic
Sex 
 
male
female
18
16
Age (years) mean
range
42.8
17-75
Duration of pain (months) mean
range
44.0
4-142
Dominant hand 25
Number of previous operations
 
0
>1 
median (range)
15
19
1 (0-5)
BMI mean
range
26.4
17-37
Social economic status
  
high
medium
low
12
18
4
Smoking  status
  
current smokers
past  smokers
never smoked
12
12
10
Employed 15
Workers compensation 18
Litigation involved 13
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The study population consisted of 18 males and 16 females with an average age 
of 42.8 years. The average duration of follow-up was 22 months (range 3-37). The 
causes of nerve injury are presented in table 2.  There were 9 amputation injuries. 
There was no significant difference in outcome between traumatic and iatrogenic 
injuries or the type of injury (sharp, crush, avulsion).
Nineteen patients (56%) were satisfied with treatment results. The mean pre-
operative VAS score was 6.6, and decreased to 4.8 after follow up (p<0.0001). In the 
satisfied patient group, the mean pain decrease was 3.0 (from 5.7 to 2.7) compared to 
0.7 (from 7.8 to 7.1) in the unsatisfied group (p=0.003). Fourteen patients (41%) had 
a decrease of at least 3 points on the VAS for pain, or a score below 2. 
Pre- and post-operative SF-36, TSK, CISS, SCL-90 and MPQ scores, as well 
as normative population scores, are presented in table 3. Neuroma pain patients had 
a significantly lower physical quality of life compared to the normative population 
(p<0.01). Upper extremity disability (DASH), and cold intolerance (CISS) scores 
were high (p<0.01). The mental quality of life (SF-36, MCS) was no different from 
a normal population and there was no increase in symptoms of psychopathology 
(SCL-90) compared to the normative population. After surgery, upper extremity 
function improved significantly (p=0.003). For the McGill pain score, only the evalu-
ative dimension was significantly improved (PRI-e 6.8 vs. 5.4, p<0.05). 
Different pain modalities and their improvement following surgical treatment 
are shown in table 4. Pain at pressure was most frequently rated as severe prior to 
surgery and significantly improved after follow up (p<0.01). Pain with movement 
table 2. Causes of injury
Injury N
Trauma 
Sharp
Crush
Avulsion
20
8
8
4
Iatrogenic (sharp)
Arthrodesis
De Quervain’s release
Ganglion 
Ligament (S-L, Eaton Littler)
CTS release
Fasciotomy
Bone (sequestrotomy)
Flap (tissue expander)
13
3
2
2
2
1
1
1
1
Unknown 1
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and hypersensitivity also improved (p0.03). However, the number of patients with no 
complaints of hypersensitivity did not decrease following surgical treatment.
For patients satisfied with the result of surgical treatment, the use of all types 
of pain medication had decreased (table 5). In the unsatisfied group, the use of most 
types of pain medication increased after follow-up.  The frequency of pain medication 
usage showed the same pattern (table 6): in unsatisfied patients, the frequency of usage 
increased after follow up; while in satisfied patients, the frequency of pain medication 
usage clearly decreased following surgery (p=0.055). After follow-up, none of the 
patients with a good treatment result used pain medication on a daily basis, while 30% 
of unsatisfied patients did.
Data on pre-operative diagnostic nerve blocks was recorded for 18 patients at the 
outpatient clinic. There was no significant relationship between duration of pain and 
nerve block effect. The amount of remaining pain following diagnostic nerve block, 
was significantly correlated with the post-operative pain score on the VAS (figure 1; 
Spearman’s rho=0.538, p<0.05). Patients with an effective diagnostic nerve block (pain 
score less than 3.5), had significantly less pain following surgery compared to patients 
with an ineffective nerve block (VAS score 3.8 vs. 8.2, p=0.001). 
Success rates of the various surgical procedures performed during the study can 
be found in table 7. Neuromas of the superficial branch of the radial nerve (SBRN) 
led to the worst outcome, with only 33% of procedures providing satisfactory results. 
Post-operative satisfaction rates were not significantly different between the different 
affected nerves or performed surgical procedures.
There were several prognostic factors related to insufficient pain relief after 
surgical neuroma treatment; the relative risks are presented in table 8. Longer dura-
tion of pain was significantly correlated to a higher post-operative VAS score for 
pain (r=0.387, p=0.02) and the mean VAS score was higher after a duration of at 
least 48 months (VAS 6.1 vs. 4.1). The number of previous procedures did not influ-
ence primary outcome, neither did sex or socio-economic status. Before treatment, 19 
patients (56%) were unemployed, including two patients who were retired, and after 
follow up 6 of these unemployed patients had returned to work. 
Patients that were employed during surgery demonstrated a greater decrease in 
VAS score than patients that were unemployed (p<0.05). 18 patients (53%) received 
workers compensation before surgery, this decreased to 10 (29%) after surgical treat-
ment. A total of 13 patients (38%) were involved in litigation. Workers compensation 
and litigation were not predictive of the outcome.
Patients who smoked at the time of surgery had a significantly worse outcome 
than patients who did not smoke (mean post-operative VAS score 3.5 vs. 6.8, p=0.001). 
The RR of smoking on insufficient pain relief was 2.06 (95% CI: 1.24 - 3.42) This 
RR was evaluated for confounding by duration of pain, employment status and age. 
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table 5. Pain medication usage in satisfied and unsatisfied patients
Pain medication Number of unsatisfied patients 
(n=15)
Number of  satisfied patients 
(n=19)
Pre-operative Follow-up Pre-operative Follow-up
Paracetamol 1 4 3 2
NSAID 5 3 5 4
Weak opiate 0 2 0 0
Strong opiate 1 1 0 0
Adjuvant 3 4 3 2
Other 0 4 0 0
table 6. Frequency of pain medication usage in satisfied and unsatisfied patients
Frequency Number of unsatisfied patients 
(n=15)
Number of  satisfied patients 
(n=19)
Pre-operative Follow-up Pre-operative Follow-up
>3 times a day 3 5 3 0
1-2 times a day 3 4 2 0
> Once a week 0 0 3 3
Once a week 0 1 0 2
Less often or never 9 5 11 14
Wilcoxon signed-rank test for difference in usage between pre-operative and follow-up periods: 
unsatisf ied patients: p=0.08 (increased usage); satisf ied patients: p= 0.055 (decreased usage)
table 4. Pain modalities
Pain modality Severe Moderate Mild None p-value
Pre Post Pre Post Pre Post Pre Post
Spontaneous pain 15 10 10 13 4 4 4 7 0.14
Pain at pressure 25 15 5 11 1 4 2 4 0.009
Pain with movement 19 11 9 11 1 9 4 3 0.03
Hypersensitivity 22 13 5 11 1 5 5 5 0.03
Pre- and post-operative grading of different pain modalities by patients.; p-value: obtained with 
Wilcoxon signed rank test
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figure 1. Graph: pain after diagnostic nerve block vs. post-operative pain
Spearman’s rank correlation coeff icient: 0.538, p<0.05 
table 7. Patient satisfaction following different surgical procedures 
Procedure N Satisfied (%)a
Neuroma treatment
Digital nerve
SBRN
LABCN
Dorsal ulnar nerve
PBMN
42
18
18
4
1
1
18 (43%)
9 (50%)
6 (33%)
3
1
0
Relocation into muscle
Relocation into bone
Nerve repair (incl. neurotube, autograft)
Relocation elsewhere (incl. loop, nerve sheath)
10
9
6
17
4 (40%)
3 (33%)
3 (50%)
8 (47%)
Neurectomy adjacent nerves (secondary procedure) 10  4 (40%)
a Satisfaction percentages calculated for N>5; SBRN: superf icial branch of the radial nerve; LABCN: 
lateral antebrachial cutaneous nerve; PBMN: palmar branch of the median nerve
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The pooled RR estimates ranged between 2.08 and 2.29, indicating no confounding 
of these factors, and there was no clear effect modification present. Smoking was 
significantly related to a lower BMI (23.7 vs. 27.9, p<0.05) and there was some effect 
modification present (table 9). Patients with a normal BMI did not show the same 
deteriorating effect from smoking, compared to patients with a BMI above 25 (RR 1.2 
vs. 3.7). The same was found for sex: males had a lower RR for smoking on outcome 
than females (RR 1.7 vs. 3.0). Past smoking was not related to a worse outcome and 
even showed better pain relief than never smokers, with a mean post-operative VAS 
score of 2.6. Outcome was not related to the number of pack years smoked or the 
duration of smoking cessation prior to surgery. 
table 9. Stratification of smoking on BMI and sex
Stratified by RR
BMI 
  
<25
>25
1.23 (0.72-2.10)
3.75 (1.62-8.68)*
Sex 
  
male
female
1.73 (0.83-3.61)
3.00 (1.19-7.56)*
RR: relative risk ratio of smoking for insufficient pain relief; *p<0.05
table 8. Prognostic factors
Variable N Follow-up 
VAS score
Satisfied (%) Insufficient 
pain relief
RR
Duration of pain
  <48 months
  >48 months
24
10
4.1
6.1
16
3
12
8 2.50 (0.68-9.20)
Diagnostic nerve block 
  VAS score <3.5
  VAS score >3.5
12
6
3.8
8.2**
8 
1
6
6 2.00 (1.14-3.52)
Smokes
  yes
  no
12
22
6.8
3.5**
4
15 
11
9**
2.06 (1.24-3.42)
Employed
  yes
  no
15
19
3.2
5.9*
11
8 
6
14* 1.84 (0.94-3.62)
RR: relative risk for insufficient pain relief, defined as at less than 3 points decrease on the VAS, or a final 
score higher of 2 or higher; *p<0.05; ** p<0.01
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Discussion
Painful neuromas are often therapy resistant.  When referred to pain management 
teams, neuroma patients are often regarded as having no chance of improvement 
of their symptoms. It is relatively unknown that in some patients, peripheral nerve 
surgery can provide a permanent effect on pain relief, as opposed to the life-long use 
of analgesic medication or medical devices (e.g. nerve stimulators).
This prospective follow up study was performed to evaluate the result of treat-
ment on multiple outcome domains and to establish prognostic factors for insufficient 
pain relief following surgical treatment. Furthermore, we looked at the predictive 
value of commonly used diagnostic nerve blocks. We found that 56% of patients were 
satisfied with treatment results. There was a significant decrease in pain and dis-
ability and little or no improvement in cold intolerance, quality of life, or symptoms 
of psychopathology. Evaluating patient and surgery specific determinants, we found 
several prognostic factors predictive of insufficient pain relief including unemploy-
ment, nicotine use and poor pain relief following diagnostic nerve block. 
To accurately study the effect of treatment for neuropathic pain, the use of 
appropriate outcome measures is essential.23 Most studies performed in the area of 
neuroma pain focus on only one aspect of treatment outcome,24-29 The Initiative on 
Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) recom-
mended 6 core outcome domains that should be considered in chronic pain research: 
pain; physical functioning; emotional functioning; improvement and satisfaction with 
treatment; other symptoms and adverse events during treatment; and patients’ dispo-
sition and characteristics.17 We assessed all of these areas using previously validated, 
reliable measures.
Reliable pain measurement is difficult, since pain is a highly subjective symptom. 
Other studies often use ill defined or non validated outcome measures for pain.28,30-34 
We applied the VAS to assess pain pre- and post-operatively and used cut-off scores 
for a reliable and clinically useful decrease in pain on the VAS.14
Remaining or recurrent pain after surgical neuroma treatment can be explained 
by secondary displacement of the translocated neuroma, failure to identify the pres-
ence of more than one neuroma in the same patient,33 or injury of neighboring nerve 
branches. Following complete neurectomy of the injured nerve, adjacent nerves may 
start to transmit sensory signals from the denervated skin area.35 This process is desir-
able for normal sensory recovery, but can lead to recurrent or sustained pain in surgi-
cally treated neuroma pain patients. There is increasing evidence that hyperalgesia is 
independent of input from injured afferents, suggesting that ectopic activity originat-
ing from a neuroma is not necessary for development of hyperalgesia.36-38 As previ-
ously described by Stokvis et al.2, patients surgically treated for a painful neuroma in 
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the upper extremity showed a significant decrease in spontaneous pain after follow up. 
However, the intense symptoms of cold intolerance, also called thermal hyperalgesia, 
remained unchanged. In our study, symptoms of hypersensitivity improved to some 
extent. However, the number of patients without any hypersensitivity did not decrease 
following surgical treatment.
Careful patient selection for surgical treatment is critical for a successful outcome 
of neuroma pain treatment.9 In the diagnostic workup of neuroma pain patients, a 
diagnostic nerve block with 1% lidocaine is often performed.13  It is proposed that 
insufficient pain relief following a diagnostic block is a contraindication to surgery.33 
Unfortunately, more has been written on the description of techniques of various 
nerve blocks than on evaluating the benefits to the patient,39 and statistically signifi-
cant evidence for the diagnostic or prognostic value of peripheral nerve blocks for 
neuroma pain diagnosis has, to our knowledge, not been described in literature before. 
We found the effect of a diagnostic peripheral nerve block to be significantly predic-
tive of the amount of pain following surgery for painful neuromas. For patients with a 
good response to the block, success chances were significantly higher. We should take 
into account the fact that the majority of patients with an unsuccessful nerve block 
were not surgically treated and were not included in our study. This may bias the 
predictive value of an unsuccessful diagnostic nerve block, since the patients that were 
operated despite the poor block result, may represent a different patient group than 
patients that were not operated. It emphasizes the need for placebo controlled studies 
in determining the true predictive value of this often used diagnostic tool.  
Longer duration of pain was significantly correlated to a higher post-operative 
VAS score for pain. This is common finding in literature, and may be explained by 
changes in pain processing in the central nervous system (CNS) that can occur during 
the chronic phase of neuropathic pain and sustain patients’ pain.7 However, patients 
with a highly therapy resistant pain problem will subsequently have a longer duration 
of pain and more surgical procedures, regardless of the cause. 
Employment status was related to a better outcome, and the literature on neuroma 
pain outcome supports this result.7. The finding by Suter40 that employed patients  had 
less severe symptoms prior to treatment was also present in our patient population; 
however, we also found a significantly greater improvement in pain score for employed 
patients.  Furthermore, Suter stated that employed patients experience a feeling of 
satisfaction that alleviates the perception of pain and disability and that working 
facilitates recovery from injury. Therefore, it would be valuable to focus on activity 
and employment in the treatment and rehabilitation of chronic pain patients.4
Nicotine is known to have central analgesic properties in humans, but paradoxi-
cally, also has peripheral nociceptive effects. Chronic nicotine use produces a stable, 
long-lasting, mechanical hypersensitivity that exacerbates mechanical sensitivity 
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resulting from peripheral nerve injury.41 The effect of nicotine on neuropathic pain 
has become increasingly known in basic research. However, clinical research is to 
our knowledge restricted to a single case series with two patients. In this study by 
Richards et al 42, patients experienced a marked reduction in neuropathic pain follow-
ing smoking cessation, and their pain returned once they resumed smoking. In our 
study, smokers had a significantly worse outcome, with less reduction in pain and a 
lower satisfaction compared to non smokers.  We found a RR of smoking on insuf-
ficient pain relief of 2.1 (1.2 - 3.4). 
In males and patients with a low BMI, the deteriorating effect of smoking was 
less obvious. This might be explained by the absence of a central analgesic effect of 
nicotine on pain in women. In a study by Jamner et al.43, the transdermal administra-
tion of nicotine led to decreased sensitivity to pain in men but not in women, sug-
gesting a difference in the central effect of nicotine on pain regulatory mechanisms 
between men and women. 
Although the exact mechanism of nicotine on neuropathic pain, influenced by 
BMI and gender, needs to be elucidated, smoking cessation in patients sustaining 
plastic surgery should be encouraged.44,45 Chronic exposure to cigarette smoke pro-
duces profound changes in physiology that may contribute to peri-operative morbidi-
ty.44 It is known to impair digital blood flow and wound healing in the hand46,47 and 
increases the risk of postoperative wound-related complications, such as dehiscence 
and wound infection.44,48 
There are some limitations to this study that should be discussed. Our study 
population existed of patients referred to a tertiary referral center for expertise in the 
field of neuropathic pain treatment, sometimes following multiple ineffective treat-
ments. This is likely reflected in the severe and therapy resistant nature of our patients’ 
complaints and therefore negatively influences outcome compared to other medical 
centers and neuropathic pain disorders. 
We included neuropathic pain patients with neuromas of any of the peripheral 
sensory nerve branches in the upper extremity. This has provided a somewhat het-
erogeneous patient group, with some subgroups of more rarely affected sensory nerve 
branches, but increased the overall applicability of our outcomes. 
Given the reasonably low incidence of painful neuromas, our study was based 
on a relatively large number of patients. Most studies that have been performed 
evaluating painful neuroma treatments comprised case series with small patient 
numbers,12,24,29,49-54 or had a retrospective design.34,55,56
Our study was conducted as a prognostic follow up study. This type of study is 
readily used to accurately study prognostic factors for treatment outcome. Since data 
collection was prospective, information bias was largely avoided and response rates 
were high. We were able to compare pre-and post-operative findings for all included 
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patients, with complete follow up for 34 out of 35 patients returning the primary 
questionnaire.
Neuroma pain following upper extremity nerve injury remains a difficult problem; 
patients experience high disability and low quality of life. Surgical treatment can 
effectively decrease pain, disability and workers compensation rates. Unfortunately, 
insufficient pain relief following surgical neuroma treatment is a common finding. 
Our results could lead to improved patient selection and treatment strategies. If a 
diagnostic nerve block is ineffective in relieving pain, patients will most likely not 
benefit from surgical treatment. Patients should be encouraged to focus on activity 
and employment instead of their symptoms. Smoking should be strongly discouraged 
in all patients who will undergo surgical neuroma treatment.
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General Discussion
The purpose of this thesis was to explore why a large number of patients with neuroma 
pain still have insufficient pain relief following surgical neuroma treatment, and to 
explore the optimal strategies for surgical treatment and chronic pain prevention 
of individual patients. In the previous chapters we have presented our results. The 
outcome of our studies will subsequently be used to answer the research questions 
posed in the introduction.
Patient selection
Which are important prognostic factors for insuff icient pain relief?
After reviewing the literature (chapter 2) and performing a prognostic follow-up study 
(chapter 7) we found the following prognostic factors for a worse outcome following 
surgical neuroma treatment:
Neuromas of the superficial branch of the radial nerve•	 1,2
Neuromas of digital nerves•	 2,3
No ‘discrete nerve syndrome’•	 4
Receiving workers’ compensation•	 2,3,5,6
Unemployment•	 4,6
Litigation involvement•	 4,7
Increasing number of previous operations•	 2,6
Longer duration of pain•	 6
Smoking•	 8
The superficial branch of the radial nerve (SBRN) is vulnerable to the formation of 
painful neuromas that are difficult to treat, due to its anatomical location and overlap-
ping sensory pattern with neighboring nerves.6 
Incorrect relocation, into a small muscle with significant excursions (i.e. intrinsic 
or thenar musculature), can cause insufficient pain relief. In chapter 5 we observed 
that approximately 89% of patients with SBRN relocation into small muscles or bone 
were unsatisfied following surgical treatment. Patients with neuromas of the digital 
nerves face the same problems in achieving satisfactory outcome.
Discrete nerve syndrome is a collective term for a condition in which a single 
nerve can account for both the neurological findings and the distribution of neuro-
pathic pain.4 Patients with poorly localized, ill-defined signs and symptoms will likely 
have an increased chance of being incorrectly diagnosed and receiving inappropriate 
treatment.
In chapter 2, we learned that patients seem to benefit less from treatment when 
continued disability is important for their pending litigation. In this context, patients 
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involved in workers’ compensation can have an interest in reporting poor outcome. 
Litigation and workers’ compensation were not predictive of a worse (reported) 
outcome in our prospective follow-up study (chapter 7). This seeming contradiction 
could well be explained by differences between the litigious climates of the countries 
were these studies were performed. 
Being employed increases the chance of a satisfactory outcome following surgi-
cal neuroma treatment (chapters 2 and 7). Although in chapter 7 employed patients 
had less severe symptoms prior to treatment, we also found a greater decrease in pain 
score for employed patients. In chronic pain patients, employment can lead to lower 
physical and emotional distress.9 
Patients with a longer duration of pain have an increased chance of insufficient 
pain relief following surgical neuroma treatment; this relation was observed in chap-
ters 2, 5 and 7, and may be explained by changes in pain processing in the central 
nervous system (CNS) that can occur during the chronic phase of neuropathic pain 
and sustain patients’ pain.10-12 Furthermore, patients with a highly therapy resistant 
pain problem regardless of its cause, will subsequently have a longer duration of pain 
and are more likely to undergo multiple surgical procedures. 
A prognostic factor found in chapter 7 that has not been reported in neuroma 
pain literature before, is smoking. Smokers have a significantly worse outcome follow-
ing surgical neuroma treatment, with less reduction in pain and a lower satisfaction 
rate compared to non smokers. The relative risk (RR) of smoking on insufficient pain 
relief is 2.1. With a prevalence of smoking of 35% our patient population, a great 
benefit may be achieved by stimulating smoking cessation.8,13,14
Diagnosis
Can we use ultrasonography for diagnosis and localization of neuromas in the 
upper extremity?
Ultrasonography (US) equipment used in clinical settings has reached frequencies up 
to 20MHz at present and frequency and resolution are steadily increasing. Known 
advantages of US are its noninvasiveness, safety, portability and low costs. High-
resolution US was able to depict the small cutaneous nerve branches in the hand and 
wrist that are often involved in neuroma formation. In chapter 3, the sensory branch 
of the radial nerve, the palmar branch of the median nerve, the dorsal branch of the 
ulnar nerve and the palmar digital nerves were visualized in great detail using the 
Vevo 770 US system with 15-82.5 MHz real-time micro visualization scan heads. 
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Using this technique, it will be possible to assess individual nerve fascicles in a 
damaged peripheral nerve and determine the degree of injury in neuroma in continu-
ity lesions. When the exact location of an upper extremity neuroma is unclear, US may 
help in surgical planning and reduce the size of surgical incisions and wound beds.15,16 
Furthermore, high resolution US can serve to locate the cause of remaining or recur-
rent pain following surgical neuroma treatment, i.e. the unintentional dislocation of 
a relocated nerve end.
Is the diagnostic nerve block a predictive diagnostic tool?
Misdiagnosis and failure to identify the presence of distal reinnervation or central 
sensitization may be avoided by the use of a local diagnostic nerve block, which can 
identify the sensory nerves involved in the neuropathic pain symptoms.6,17 In chapter 
7, we found the effect of a diagnostic peripheral nerve block to positively predict the 
effect of surgical neuroma treatment. 
Unfortunately, false positive results were common. This could be explained by 
the placebo effect of the block, which is common in chronic pain patients.18-20 There 
was no data from patients that received a diagnostic nerve block, but did not undergo 
surgery. Therefore, this test’s sensitivity or specificity could not be calculated.
In chapters 5 and 7, all patients who underwent surgery following an ineffective 
diagnostic nerve block experienced insufficient pain relief at follow-up. This indicates 
that these patients should not sustain surgery and be referred to a pain specialist for 
alternative options to reduce pain.
Determinants of outcome
Which are the most important outcome measures for peripheral neuropathic pain 
research? 
In chapter 6 we studied possible outcome measures on their importance for patient 
satisfaction following surgical neuroma treatment. Pain, measured with a visual ana-
logue scale (VAS), the evaluative dimension of pain according to the McGill Pain 
Questionnaire (MPQ PRI-e) and disability, measured with the DASH and SF-36 
physical component, are the most important outcome domains. Other symptoms that 
are important for patient outcome are cold intolerance (CISS) and activity avoidance 
due to fear of re-injury (TSK-AA). Which outcome measure should be chosen in 
clinical practice depends on the amount of time available and the specific questions 
that need to be answered. The use of time consuming instruments, i.e. the MPQ, gives 
a more specific evaluation of the patient’s problem, while short measures, such as the 
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VAS, have a higher response rate. 
A presumed disadvantage of the VAS has been that patients may adjust their 
criteria for success over time by becoming less stringent.21 The results from chapter 
6 provide a different conclusion: the amount of pain on a VAS indicated as tolerable 
by neuroma pain patients does not change following surgical treatment. The VAS has 
a good test-retest reliability (r=0.8022), is easy-to-use in clinical practice and readily 
interpretable by the clinician. A decrease of at least 30 mm or a score below 20 mm 
on the VAS represents a relevant change in pain. These cut-off points were used to 
evaluate patients’ outcome in chapter 7.
Treating hyperalgesia
Can hyperalgesia be sustained by pain conduction via adjacent nerves; and how 
can we treat this hyperalgesia?
As described in chapter 4, cold intolerance, or thermal hyperalgesia, has a prevalence 
of 91% in patients surgically treated for neuroma pain. Although surgery signifi-
cantly decreases spontaneous neuroma pain, it does not improve symptoms of cold 
intolerance. In chapter 7 we found similar results: symptoms of hypersensitivity are 
improved to some extent following surgical treatment, but the proportion of patients 
with symptoms of hypersensitivity does not decrease.
These findings can be explained by the observations made in small animal 
research, that ectopic activity originating from a neuroma is not necessary for the 
development of hyperalgesia.23-25 The recruitment of axons from adjacent nerves will 
continue the input of pain signals to the CNS. This process is desirable for normal 
sensory recovery, but can lead to recurrent or sustained pain in surgically treated 
neuroma pain patients. Furthermore, injury to a cutaneous branch of a peripheral 
nerve can result in central sensitization that spans multiple spinal segments and can, 
therefore, cause pain to be perceived in neighboring nerve distributions.26
In chapter 5, the problems in achieving satisfactory pain relief for a population 
of patients with neuropathic pain of the SBRN was studied. It seems that the recruit-
ment of adjacent nerves may be a significant cause for insufficient relief from pain and 
hyperalgesia. In accordance with this theory, neurectomies of neighboring nerves such 
as the LABCN and PIN have relatively good satisfaction rates (approximately 50%) 
for this hard-to-treat patient population.
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Clinical implications
What is the most effective treatment strategy for neuroma pain patients?
Neuroma pain patients experience very high disability and low quality of life com-
pared to a normal population. Many treatment methods have been proposed, such as, 
injections of the nerve stump with various chemical agents, transcutaneous electrical 
nerve stimulation (TENS), topical lidocaine, repeated nerve blocks, desensitization 
techniques and adjuvant pain medication like antidepressants and anticonvulsants.27 
Although pain specialists are not always aware of this option, peripheral nerve surgery 
can provide a permanent effect on pain relief, as opposed to the life-long use of 
analgesic medication or medical devices. Currently used treatment strategies focus 
primarily on surgical repair or denervation of the injured nerve. As we observed in 
chapter 7, surgical neuroma treatment effectively decreased pain and upper extremity 
disability in approximately 50% of patients. Unfortunately, the other 50% experienced 
insufficient pain relief. 
In chapter 5 we compared treatment methods for SBRN neuralgia, known for 
its unfavorable outcome. Nerve repair often fails to provide a satisfactory outcome. 
Preferably, denervation with relocation of the nerve end into the brachioradial muscle 
should be performed without undue delay. Relocation of the nerve end elsewhere (i.e. 
small muscles of the hand and lower arm, the distal radius, end-to-side anastomosis) 
has only an 11% chance of achieving patient satisfaction. 
From the results found in chapters 2, 4, 5 and 7 we can propose a general treat-
ment strategy for painful neuromas in the upper extremity:
Patients presenting to any clinician with complaints suspect of neuroma pain not 
responding to desensitization or adjuvant pain control should be referred to a Plastic/
Hand Surgeon without delay, to assess the possibilities for surgical treatment. The 
diagnosis of neuroma pain can be made with a thorough medical history and physical 
examination. If the diagnosis remains unclear, a high resolution US examination of 
the suspected nerve(s) should be performed. 
To assess central centralization processes, damage to multiple nerves and the 
role of neighboring nerves in transmitting pain signals, a diagnostic block of the most 
likely involved nerves should be performed. Patients with no or little pain reduction 
following this diagnostic block should not undergo surgical neuroma treatment. 
Patients should be properly informed about the expected effects of surgical 
treatment. They should be encouraged to focus on activity and employment instead of 
focusing on their symptoms. Smoking should be strongly discouraged. 
When a patient is found eligible for surgical neuroma treatment, effort should be 
made to perform the procedure without delay. During surgery, the neuroma is excised 
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and the nerve end placed preferably into a sufficiently large, well vascularized muscle 
bed without large excursions. In case of an overlapping sensory pattern of adjacent 
nerves, these are neurectomized to decrease post-operative hyperalgesia. It is unlikely 
that symptoms of cold intolerance are improved by denervation of the injured nerve.
Case – continued 
What happened to Mr. Dolor?
In August 2009, Mr. Dolor sustained an US examination of the operated area. It 
seemed that the SBRN had been pulled out of the thenar musculature and had 
formed a new neuroma located superficially beneath the skin. Diagnostic nerve 
blocks of the SBRN and PIN performed at the outpatient clinic significantly decreased 
symptoms of pain and hyperalgesia. After being explained the potential benefits to 
his recovery and outcome, Mr. Dolor started working therapeutic hours and entered 
a smoking cessation program.
In November 2009, the SBRN was surgically relocated into the brachioradial muscle 
and after that a PIN neurectomy was performed. Following his recovery, Mr. Dolor’s 
pain and hyperalgesia improved to a tolerable level. He returned to his previous 
job as a plastic processer and was again able to perform his tasks as a father of two 
young children.
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Recommendations for future research 
Today, there are still patients who do not benefit from surgical neuroma treatment 
and some interesting topics for future research remain. 
Research comparing epidemiological, patho-histological and molecular biologi-
cal characteristics of nerve injury patients with and without chronic neuropathic pain 
could provide new insights in its etiology and pathogenesis of painful neuromas. Novel 
peripheral nerve imaging techniques like high resolution ultrasound16 and diffusion-
tensor imaging28 are rapidly improving and will be able to aid the diagnostic and 
follow-up processes of patients undergoing surgical treatment.
The accuracy of diagnostic nerve blocks, in selecting patients eligible for sur-
gical neuroma treatment, should be further determined. A randomized controlled 
trial using placebo controlled nerve blocks and subsequent surgical treatment would 
provide accurate estimates of this test’s sensitivity and specificity.18 However, since 
the diagnostic nerve block is already considered the gold standard to assess surgical 
eligibility, this type of research might raise important ethical issues.
A well-designed randomized trial would also be appropriate to compare seem-
ingly effective surgical treatment strategies. To date, only one RCT has been performed 
in the field of neuroma pain treatment,29 and its patient numbers were relatively small; 
the study compared two surgical treatment methods in 20 lower extremity neuroma 
patients. To increase the power of statistical analyses, large patient numbers are desir-
able. However, given the fact that neuroma pain is (fortunately) uncommon, large 
study populations are hard to obtain. Multicenter studies could provide sufficiently 
large patient numbers needed for high quality research.
New insights in human neurobiology will provide possibilities for the develop-
ment of new types of drugs for neuropathic pain treatment. Several key molecules 
associated with nociception have been suggested as potential targets. One example is 
glial cell line-derived neurotrophic factor (GDNF), which has shown to exert a potent 
analgesic effect on hyperalgesia as well as a protective effects against the development 
of neuropathic pain in rats.30,31
A completely new therapeutic strategy, gene therapy, could be used to treat and 
even prevent painful neuromas in the future. It has already been used to express neural 
growth factors guiding peripheral nerve regeneration32 and may also be used to inhibit 
the expression of local proteins essential for neuroma formation.33 
To ensure best medical practice, clinicians should continue to familiarize them-
selves with the rapidly progressing field of neuropathic pain treatment. They should 
stay aware of the available options for treating, and ultimately preventing painful 
neuromas.
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Final considerations
As we are nearing the end of the Decade of Pain Control and Research, it is important 
to reflect on what has been accomplished in the management of chronic neuropathic 
pain, as well as the challenges that lie ahead.  
There has been an enormous increase in knowledge of the nature and mechanisms 
of pain. Great effort has been made to objectively measure symptoms of pain. The next 
ten year period has been appointed the ‘Decade of the Mind’, and will undoubtedly 
lead to even greater insights in the origin and treatment of chronic neuropathic pain. 
It is important to remember however that pain is a subjective experience by definition, 
and relieving patients’ suffering must be the ultimate goal of any treatment. 
New techniques to (surgically) treat pain have to make the leap from bench to 
bed in order to be effective. The clinician then has to decide whether what is possible is 
also desirable in the context of Hippocrates’ “do no harm”. All of these considerations 
have to be made against rapidly changing legal, economic and social backgrounds.34
It is important to acknowledge that neuropathic pain management requires a 
personalized approach, taking into account the broad scale of physical, emotional, and 
social problems that affect the daily life of chronic neuropathic pain patients.
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Chapter 1: Introduction
The major impact of chronic pain on public health is reflected by the declaration of 
the present decade as the “Decade of Pain Control and Research”, mandated by the 
USA Congress. Neuropathic pain is thought to be a particularly distressing chronic 
pain condition that is often under-diagnosed and under-treated. Approximately 3-5% 
of all patients involved in peripheral nerve injury develop a symptomatic neuroma. 
Symptomatic neuromas cause intense spontaneous burning, shooting or electric pain, 
lowered thresholds for pain (hyperalgesia) and pain at touch (allodynia). Patients 
with a painful neuroma usually experience great disability, leading to high costs for 
society.
A neuroma is formed by the combination of regeneration of neural fibers and 
excessive fibrous tissue proliferation, which results in contraction of nerve fibers 
within the scar tissue. Its diagnosis is usually based on patients’ history and clinical 
examination, including a Tinel’s test and a diagnostic nerve block. Although many 
treatment methods have been proposed, none has shown to be entirely effective in 
achieving sufficient pain relief.
Objective and research questions
The purpose of this thesis was to explore why a large number of patients with neuroma 
pain still have insufficient pain relief following surgical neuroma treatment, and to 
explore the optimal strategies for surgical treatment and chronic pain prevention of 
individual patients. The following research questions were discussed in this thesis:
Which are important prognostic factors for insufficient pain relief?•	
Can we use ultrasonography for diagnosis and localization of neuromas in the •	
upper extremity?
Is the diagnostic nerve block a predictive diagnostic tool?•	
Can hyperalgesia be sustained by pain conduction via adjacent nerves; and how •	
can we treat this hyperalgesia?
Which are the most important outcome measures for peripheral neuropathic pain •	
research? 
What is the most effective treatment strategy for neuroma pain patients? •	
Chapter 2: Insufficient pain relief after surgical neuroma treatment 
Patient-specific prognostic factors, predicting insufficient pain relief after surgical 
neuroma treatment, can help clinicians in the process of patient selection, treatment 
and care. We performed a review of the literature to evaluate these prognostic factors. 
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A computerized bibliographical database (PubMed Medline) was searched for relevant 
studies, and all reference lists were checked. We found 14 cohort studies that indicate 
possible prognostic factors. The factors that seem to predict the amount of postopera-
tive pain are neuromas of the radial sensory branch (RSB) and digital nerves, discrete 
nerve syndrome, workers’ compensation, employment status, litigation involvement, 
duration of pain and the number of previous operations. In chronic neuropathic pain 
patients, changes in the central nervous system at the level of spinal cord and in the 
somatosensory cortex may play a role in sustaining pain.
Chapter 3: Diagnostic ultrasonography of cutaneous nerve branches
Ultrasonography (US) can be used to identify peripheral nerves. It is a non-invasive, 
cost-effective and easy-to-use technique. However, the resolution of the current US 
equipment, with frequencies of 5–20 MHz, does not allow accurate and detailed 
visualization of the superficial cutaneous branches of the median, ulnar and radial 
nerves in the hand and wrist and digital nerves, which are often involved in upper 
extremity neuroma formation. Recent advances in US imaging techniques have per-
mitted frequencies over 80 MHz, with a spatial resolution down to 30 microns. In this 
study, we compared peripheral nerve imaging with the VisualSonics Vevo 770 system 
equipped with 15-82.5 MHz transducers to a commonly used 5-12 MHz US system, 
in two cadaver arms and two healthy test subjects. The Vevo 770 system was able to 
accurately identify the small cutaneous nerves in the hand and wrist. It could also 
depict the median nerve and its fascicles in greater detail compared to the 5-12 MHz 
US system. High resolution US could be used for clinical diagnosis, localization and 
follow-up of neuropathies and nerve injuries.
Chapter 4: Cold intolerance in surgically treated neuroma patients
Cold intolerance, or thermal hyperalgesia, is a common long-term consequence of 
upper-extremity nerve injury. It is defined as abnormal pain of the hand and fingers 
after exposure to mild or moderate cold, with or without discoloration, numbness, 
weakness, or stiffness. Cold intolerance can seriously affects patients’ lifestyle, work, 
and leisure activities. This study aimed to investigate the prevalence and severity of 
cold intolerance in patients with injury related neuromas of the upper extremity and 
improvement of symptoms after surgical neuroma treatment. The cold intolerance 
symptom severity (CISS), visual analogue scale (VAS) and disabilities of the arm, 
shoulder and hand (DASH) questionnaires were filled out by 33 patients surgically 
treated for upper extremity neuroma pain. The follow-up questionnaire was filled by 
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30 of these patients after a mean follow-up time of 24 months. We found a prevalence 
of cold intolerance of 91% before surgery, with a mean CISS score above the cutoff 
point for abnormal cold intolerance. The VAS score for pain decreased significantly 
following surgical treatment (p<0.01), and disability was also reduced. However, the 
overall severity of cold intolerance did not decrease at all. Furthermore, we found 
that duration of pain and follow-up period were unrelated to the CISS score. From 
our results, it seems unlikely that cold intolerance will fade with time or surgical 
treatment.
Chapter 5: The ‘unforgiving’ superficial branch of the radial nerve
The sensitivity of the superficial branch of the radial nerve (SBRN) for the develop-
ment of neuropathic pain is well documented, and achieving satisfactory pain relief 
remains extremely difficult. This study evaluated different surgical treatment strategies 
for neuropathic pain caused by lesions or adhesions of the SBRN. Surgical records 
were searched for patients with SBRN neuralgia. Data were collected from medical 
files. The effect of a pre-operative diagnostic nerve block was determined. Study out-
comes were patient satisfaction and post-operative pain scored with the numerical 
rating scale (NRS). Forty-nine patients underwent 34 neurolyses and 49 denervations 
of the SBRN. Multiple nerves innervating the dorsoradial wrist area were involved; 
including the posterior interosseous nerve (PIN) and lateral antebrachial cutaneous 
nerve (LABCN). 29 patients achieved satisfactory results (59%). The median NRS 
pain score decreased from 7.5 to 2.5 (p<0.001). Operations relocating the SBRN into 
the brachioradial muscle achieved significantly higher patient satisfaction rates than 
relocation of the nerve end elsewhere (p=0.04). PIN and LABCN neurectomies also 
provided satisfactory pain relief. Higher post-operative pain scores and lower success 
rates were found in patients with an unsuccessful diagnostic nerve block.
Chapter 6:  Determinants of patient satisfaction
To accurately study treatment methods for neuropathic pain, the use of appropriate 
outcome measures is essential. There is a growing demand to investigate the rela-
tionship between patient satisfaction and relevant clinical outcomes. The Initiative 
on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) 
recommended 6 core outcome domains that should be considered in chronic pain 
research. These 6 core outcome domains are (I) pain; (II) physical functioning; (III) 
emotional functioning; (IV) participant ratings of improvement and satisfaction 
with treatment; (V) other symptoms and adverse events during treatment; and (VI) 
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patients disposition and characteristics data. The purpose of this study was to find the 
outcome domains most important for patient satisfaction after surgical treatment for 
neuropathic pain, caused by peripheral nerve injury. Thirty-four patients surgically 
treated for upper extremity neuroma pain were followed prospectively. They returned 
validated questionnaires on the core outcome domains of chronic pain pre- and post-
operatively, including the VAS, McGill Pain Questionnaire (MPQ), DASH, Short 
Form-36 (SF-36), Symptom CheckList-90 (SCL-90), Tampa Scale of Kinesiophobia 
(TSK) and the CISS. Cut-off values for meaningful change were calculated using the 
reliable change index (RCI) and the clinical significant change (CSC) cut-off value. 
We compared satisfied and unsatisfied patient groups for all outcome domains. The 
most important outcome domains were found to be ‘pain’, ‘physical functioning’ and 
‘other symptoms’; ‘Emotional functioning’ was not related to satisfactory outcome. 
The VAS for pain was most important for patient satisfaction, and a decrease of at 
least 30 mm or a score below 20 mm on the VAS were found to represent relevant 
changes in pain. The amount of pain indicated as bearable by patients, did not change 
after treatment. 
Chapter 7: Surgical treatment of neuroma pain
We performed a prospective follow-up study to study the success of surgical neuroma 
treatment and evaluate prognostic factors. Primary outcomes were patient satis-
faction and pain scored pre- and post-operatively on a VAS. Secondary outcomes 
included upper extremity function, quality of life and symptoms of psychopathology. 
VAS scores after diagnostic nerve blocks were documented at the outpatient clinic 
before surgery. Surgical treatment consisted of neuroma resection and nerve repair 
or proximal transposition of the involved sensory nerve into muscle or bone. Thirty-
four patients were included, with an average follow up time of 25 months. The mean 
VAS score decreased from 6.8 to 4.9 after surgery (p<0.01), fifty percent of patients 
were satisfied with surgical results. Upper extremity function improved significantly 
(p=0.001). Neuroma patients had a significantly lower quality of life compared to a 
normal population. Patients that were employed during surgery demonstrated a greater 
decrease in VAS score than patients that were unemployed (p<0.05). The VAS scores 
after diagnostic nerve block were predictive of post-operative VAS scores (p=0.05). 
Furthermore, smoking was significantly related to worse outcome (RR 2.06, p<0.05). 
The results could lead to improved patient selection and treatment strategies.
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Chapter 8: General Discussion
In the discussion, results from previous chapters were used to answer the research 
questions posed in the introduction. Using these answers, we propose a general treat-
ment strategy for painful neuromas in the upper extremity: 
Patients presenting to any clinician with complaints suspect of neuroma pain not 
responding to desensitization or adjuvant pain control should be referred to a Plastic/
Hand Surgeon without delay, to assess the possibilities for surgical treatment. The 
diagnosis of neuroma pain can be made with a thorough medical history and physical 
examination. If the diagnosis remains unclear, a high resolution US examination of 
the suspected nerve(s) should be performed.  To assess central centralization pro-
cesses, damage to multiple nerves and the role of neighboring nerves in transmitting 
pain signals, a diagnostic block of the nerve(s) possibly involved should be performed. 
Patients with no or little pain reduction following this diagnostic block should not 
undergo surgical neuroma treatment. Patients should be properly informed about the 
expected effects of surgical treatment. They should be encouraged to focus on activity 
and employment instead of their symptoms. Smoking should be strongly discouraged. 
It seems unlikely that symptoms of cold intolerance are improved by denervation of 
the injured nerve. When a patient is found eligible for surgical neuroma treatment, 
effort should be made to perform the procedure without great delay. During surgery, 
the neuroma is excised and the nerve end placed preferably into a sufficiently large, 
well vascularized muscle without large excursions. In case of an overlapping sensory 
pattern of adjacent nerves, these are neurectomized to decrease post-operative hype-
ralgesia. Furthermore, it is important to acknowledge that neuropathic pain manage-
ment requires a personalized approach, for individual patients. 
During the Decade of Pain Control and Research there has been an enormous 
increase in knowledge concerning chronic neuropathic pain and its treatment options. 
To ensure best medical practice, clinicians should continue to familiarize themselves 
with this rapidly progressing field of research. 
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Hoofdstuk 1: Inleiding
De grote invloed van chronische pijn op de volksgezondheid wordt weerspiegeld 
door de verklaring van het huidige decennium (2001 - 2011) als het “Decennium van 
pijnbestrijding en het pijnonderzoek”, door het Congres van de Verenigde Staten. 
Neuropathische pijn wordt beschouwd als een zeer hardnekkige chronische pijn, 
welke vaak ondergediagnosticeerd en onderbehandeld wordt. Ongeveer 3-5% van 
alle patiënten met perifere zenuwschade ontwikkelen een symptomatisch neuroom. 
Symptomatische neuromen veroorzaken intense spontane pijn met een brandend, 
schietend of elektrisch karakter, verlaagde pijndrempels (hyperalgesie) en pijn bij 
lichte aanraking (allodynie). Patiënten met een pijnlijk neuroom raken hierdoor vaak 
ernstig geïnvalideerd. 
Een neuroom wordt gevormd door de combinatie van regeneratie van zenuwve-
zels en overmatige verbindweefseling, resulterend in een kluwen zenuwvezels verstrikt 
in littekenweefsel. De diagnose wordt meestal gesteld op basis van de anamnese en het 
lichamelijk onderzoek, inclusief de test van Tinel en een diagnostische zenuwblok-
kade. Patiënten met een pijnlijk neuroom vormen een groep die moeilijk te behande-
len is. Er zijn veel verschillende behandelmethoden voorgesteld, maar geen van deze 
is volledig effectief gebleken in het verschaffen van complete pijnverlichting. 
Doelstelling en onderzoeksvragen 
Het doel van dit proefschrift was om te onderzoeken waarom veel patiënten met een 
pijnlijk neuroom onvoldoende pijnverlichting ervaren na chirurgische neuroombe-
handeling, en om de optimale strategie voor de chirurgische behandeling en preventie 
van chronische pijn in neuroompatiënten te onderzoeken. In dit proefschrift werden 
de volgende onderzoeksvragen gesteld:
Wat zijn belangrijke prognostische factoren voor onvoldoende pijnverlichting? •	
Kunnen we echografie gebruiken voor de diagnose en lokalisatie van neuromen in •	
de bovenste extremiteit? 
Wat is de diagnostische waarde van de tijdelijke perifere zenuwblokkade? •	
Kan hyperalgesie in stand worden gehouden door de geleiding van pijn via aan-•	
grenzende zenuwen en hoe kunnen we deze hyperalgesie behandelen? 
Welke zijn de belangrijkste uitkomstmaten in het onderzoek naar perifere neuro-•	
pathische pijn? 
Wat is de meest effectieve strategie voor de behandeling van pijn in •	
neuroompatiënten? 
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Hoofdstuk 2: Onvoldoende pijnverlichting na chirurgische 
neuroom behandeling
Patiënt-specifieke prognostische factoren die onvoldoende pijnverlichting na chiru-
rgische neuroombehandeling voorspellen, kunnen van belang zijn om verschillende 
patiënten een gepaste behandeling aan te bieden. We hebben een literatuurstudie 
uitgevoerd om deze prognostische factoren te evalueren. Via een geautomatiseerde 
bibliografische database (PubMed Medline) werden 14 cohort studies geïdentificeerd 
die mogelijke prognostische factoren onderzochten. De factoren die de mate van 
postoperatieve pijn lijken te voorspellen zijn: neuromen van de sensibele tak van de 
nervus radialis en digitale zenuwen, het ‘discrete zenuw-syndroom’, een arbeidsonge-
schiktheidsuitkering, aan het werk zijn, een lopende juridische beroepszaak, de duur 
van de pijn en het aantal eerder doorgemaakte operaties. 
In patiënten met chronische neuropathische pijn vinden veranderingen in het 
centrale zenuwstelsel plaats, onder andere in het ruggenmerg en de somatosensorische 
cortex. Deze veranderingen kunnen ook een rol spelen bij het instandhouden van 
neuroompijn. 
Hoofdstuk 3: Diagnostische echografie van cutane zenuwtakken 
Echografie is een niet-invasieve, kosteneffectieve en eenvoudig te gebruiken tech-
niek welke kan worden gebruikt om perifere zenuwen te identificeren. Echter, met 
de huidige resolutie van echo-apparatuur, met frequenties van 5-20 MHz, is het niet 
mogelijk om de kleine cutane takken van de nervus medianus, ulnaris, radialis en digi-
tale zenuwen nauwkeurig en gedetailleerd af te beelden. En juist deze zenuwen zijn 
vaak betrokken bij neuroomvorming in de bovenste extremiteit. Recente ontwikkelin-
gen hebben het mogelijk gemaakt om ultrageluidsfrequenties van meer dan 80 MHz 
te bereiken. Dit gaat gepaard met een zeer hoge resolutie. In onze studie vergeleken 
we het VisualSonics Vevo 770-systeem, uitgerust met 15-82.5 MHz transducers, met 
een klinisch veelgebruikt 5-12 MHz echosysteem, op de beeldvorming van perifere 
zenuwen in twee kadaverarmen en twee gezonde proefpersonen. Met het Vevo 770-
systeem was het mogelijk de individuele fascikels van de n. medianus weer te geven. 
Het systeem was bovendien in staat om de kleine cutane zenuwen in de hand en pols 
nauwkeurig te identificeren. Hoge resolutie echografie zou in de toekomst kunnen 
worden gebruikt voor de diagnose, lokalisatie en de follow-up van neuropathieën en 
zenuwletsels. 
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Hoofdstuk 4: Koude intolerantie in chirurgisch behandelde 
neuroompatiënten
Koude intolerantie, of thermale hyperalgesie, is een veelvoorkomend lange termijn 
gevolg van zenuwletsel in de bovenste extremiteit. Koude intolerantie wordt 
gedefinieerd als abnormale pijn van de hand en vingers na blootstelling aan lichte of 
matige koude, met of zonder verkleuring, gevoelloosheid, zwakte of stijfheid. Koude-
intolerantie kan patiënten ernstig aantasten in hun werk en vrijetijdsbesteding. Het 
onderzoek had als doel om de prevalentie en ernst van koude intolerantie bij patiënten 
met een neuroom in de bovenste extremiteit te onderzoeken, evenals de verbetering 
van symptomen na chirurgische neuroombehandeling. De ‘cold intolerance symptom 
severity’ (CISS), de ‘visual analogue scale’ (VAS) en de ‘disabilities of the arm, shoulder 
and hand’ (DASH) vragenlijsten werden ingevuld door 33 patiënten, allen operatief 
behandeld voor neuroompijn in de bovenste extremiteit. De follow-up vragenlijsten 
werden ingevuld door 30 van deze patiënten, na een gemiddelde follow-up tijd van 24 
maanden. We vonden een prevalentie van koude intolerantie van 91% vóór operatie. 
Na operatie nam de ernst van koude intolerantie niet af. Dit terwijl de hoeveelheid 
spontane pijn na operatie wel significant was gedaald. Verder vonden we dat de CISS 
score onafhankelijk was van de duur van de pijn en de follow-up periode. 
Hoofdstuk 5: ‘De genadeloze’ sensibele tak van de nervus radialis 
De gevoeligheid van sensibele tak van de nervus radialis (‘sensory branch of the 
radial nerve’ of SBRN) voor het ontwikkelen van neuropathische pijn na trauma 
is welbekend. Het bereiken van voldoende pijnverlichting blijft uiterst moeilijk 
voor deze zenuw. Deze studie evalueerde verschillende chirurgische behandelstrat-
egieën voor neuropathische pijn veroorzaakt door beschadigingen of adhesies van 
de SBRN. Operatielijsten werden doorzocht naar patiënten met SBRN neuralgie. 
Patiëntfactoren werden verzameld uit medische dossiers. Ook het effect van de 
pre-operatieve diagnostische zenuwblokkade werd bepaald. De uitkomsten waren 
patiënttevredenheid en afname in pijn zoals gescoord met de ‘numerical rating scale’ 
(NRS). Negenenveertig patiënten ondergingen 34 neurolyses en 49 denervaties van 
de SBRN. Meerdere zenuwen die de dorsoradiale pols innerveren werden behan-
deld, inbegrepen de n. interosseus posterior (PIN) en de laterale antebrachiale cutane 
zenuw (LABCN). Negenentwintig patiënten waren tevreden met het resultaat van 
de behandeling (59%). De mediane NRS pijnscore daalde spectaculair van 7,5 naar 
2,5 (p<0,001). Denervaties van de SBRN met het begraven van het zenuwuiteinde in 
de m. brachioradialis waren significant vaker succesvol in het behalen van een goede 
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patiënttevredenheid ten opzichte van het begraven van de zenuw elders (p=0,04). PIN 
en LABCN neurectomieën gaven ook voldoende pijnverlichting. Een kleinere afname 
in pijnscore en lagere slagingspercentages werden gevonden in patiënten geopereerd 
na een weinig effectieve diagnostische zenuwblokkade. 
Hoofdstuk 6: Determinanten van patiënttevredenheid
Er is een toenemende vraag naar onderzoek over relatie tussen patiënttevredenheid 
en relevante klinische uitkomstmaten. Het ‘Initiative on Methods, Measurement, 
and Pain Assessment in Clinical Trials’ (IMMPACT) heeft 6 belangrijke uitkom-
sten aanbevolen bij onderzoek naar chronische pijn. Deze 6 uitkomsten zijn (I) 
pijn; (II) lichamelijk functioneren; (III) emotioneel functioneren; (IV) verbeter-
ing en tevredenheid met de behandeling; (V) andere symptomen en bijwerkingen 
tijdens de behandeling, en (VI) patiëntfactoren. Het doel van deze studie was het 
vinden van de optimale set uitkomstmaten voor de patiënttevredenheid na chirur-
gische behandeling van neuropathische pijn veroorzaakt door perifere zenuwschade. 
Vierendertig patiënten, chirurgisch behandeld voor de neuroompijn in de bovenste 
extremiteit, werden prospectief gevolgd. Gevalideerde vragenlijsten over de belan-
grijkste uitkomstmaten van chronische pijn werden pre-en postoperatief ingevuld, 
waaronder de VAS, McGill Pain Questionnaire (MPQ), DASH, Short Form-36 
(SF-36), Symptom Checklist-90 (SCL-90), Tampa Schaal van Kinesiofobie (TSK) 
en de CISS. Drempelwaarden waarden voor klinisch en statistisch betekeningsvolle 
verandering werden berekend met behulp van de ‘reliable change index’ (RCI) en de 
‘clinical significant change’ (CSC) waardes. Uitkomsten werden vergeleken tussen de 
tevreden en ontevreden patiëntengroepen. De belangrijkste uitkomstmaten bleken te 
zijn: (I) pijn, (II) lichamelijk functioneren en (V) andere symptomen. Er was geen 
relatie tussen (III) emotioneel functioneren en patiënttevredenheid. De VAS voor pijn 
was de belangrijkste uitkomst voor patiënttevredenheid, en een daling van ten minste 
3 punten of een score lager dan 2 punten op de VAS bleek een relevante verandering 
in pijn weer te geven. De mate van de pijn die door neuroompatiënten als draaglijk 
werd beschouwd, veranderde niet na de behandeling. 
Hoofdstuk 7: Chirurgische behandeling van neuroompijn
We hebben een prospectieve follow-up studie uitgevoerd, om het succes van de 
chirurgische behandeling van neuroompijn te evalueren en prognostische factoren te 
bestuderen. De primaire uitkomstmaten waren patiënttevredenheid en pijn(afname) 
gescoord met de VAS. Secundaire uitkomstmaten waren handfunctie, kwaliteit van 
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het leven en symptomen van psychopathologie. VAS scores na de diagnostische zenu-
wblokkade werden voor de ingreep gedocumenteerd op de polikliniek. Chirurgische 
behandeling bestond uit resectie van het neuroom en zo mogelijk zenuwreconstructie of 
het proximaal begraven van de betrokken sensibele zenuw in spier of bot. Vierendertig 
patiënten werden geïncludeerd, met een gemiddelde follow-up tijd van 25 maanden. 
De gemiddelde VAS score daalde van 6,8 naar 4,9 na operatie (p<0,01), 50% van de 
patiënten was tevreden met de chirurgische resultaten. De handfunctie verbeterde 
aanzienlijk (p=0,001). Wel hadden neuroompatiënten een significant lagere kwaliteit 
van leven in vergelijking met een normale populatie. Patiënten die nog werkten 
toonden een grotere afname in de VAS-score dan patiënten die werkeloos waren 
(p<0,05). VAS scores na diagnostische zenuwblokkade waren voorspellend voor de 
postoperatieve VAS scores (p=0,05). Verder was roken significant gerelateerd aan een 
slechtere uitkomst (Relatief Risico van 2,06; p<0,05). De resultaten van dit onderzoek 
kunnen leiden tot een betere selectie van patiënten en therapeutische strategieën. 
Hoofdstuk 8: Algemene Discussie 
In de discussie worden de in de inleiding gestelde onderzoeksvragen beantwoord 
en wordt een algemene strategie voor de behandeling van pijnlijke neuromen in de 
bovenste extremiteit voorgesteld:
Een patiënt die zich presenteert met klachten welke duiden op neuroompijn en 
niet reageert op desensibilisatie of adjuvante pijnbestrijding moet worden doorver-
wezen naar een Plastisch (Hand) Chirurg om de mogelijkheden voor chirurgische 
behandeling te beoordelen. De diagnose neuroompijn kan worden gemaakt op basis 
van de anamnese en het lichamelijk onderzoek. Als de diagnose onduidelijk blijft, kan 
een echo-onderzoek uitkomst bieden. Om te beoordelen of er sprake is van centrale 
sensitisatie processen, schade aan meerdere zenuwen, of naburige zenuwen die de 
pijnsignalen doorgeven, moet een diagnostische blokkade van mogelijk betrokken 
zenuw(en) worden uitgevoerd. Alleen patiënten met een aanzienlijke pijnverminder-
ing na deze diagnostische blok zijn geïndiceerd voor een chirurgische neuroombehan-
deling. Tevens dienen deze patiënten goed te worden geïnformeerd over de verwachte 
effecten van de chirurgische behandeling. Zij moeten worden aangemoedigd om zich 
te concentreren op (werk)activiteiten in plaats van hun symptomen en beperkingen. 
Roken moet sterk worden ontmoedigd. Wanneer een patiënt in aanmerking komt 
voor chirurgische neuroombehandeling, moet ernaar worden gestreefd binnen een jaar 
na het ontstaan van de klachten te opereren. Tijdens de operatie wordt het neuroom 
geëxcideerd en het zenuwuiteinde bij voorkeur begraven in een voldoende grote, goed 
doorbloede spier, zonder grote bewegingsexcursies. In het geval van een overlappend 
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sensibel patroon met aangrenzende zenuwen, kunnen deze worden doorgnomen om 
de kans op post-operatieve hyperalgesie te verkleinen. Verder is het belangrijk te 
erkennen dat bij de behandeling van neuropathische pijn een persoonsgerichte aanpak 
nodig is, gericht op individuele patiënten.
Gedurende het decennium van de pijnbestrijding en het pijnonderzoek is er 
een enorme toename geweest in kennis over chronische neuropathische pijn en haar 
behandelopties. Om een goede kwaliteit van zorg te behouden, moeten artsen zich 
vertrouwd blijven maken met dit snel vorderende onderzoek. 
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